<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>Prognostic Reviews: Predicting Patient Futures</title>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:wght@400;600;700&amp;family=Source+Sans+Pro:wght@400;600&amp;display=swap" rel="stylesheet"/>
<style>
:root {
  --navy: #1E2761;
  --deep-navy: #141B3D;
  --gold: #D4AF37;
  --cream: #FAF8F5;
  --red: #BF2D2D;
  --teal: #2D8B8B;
  --light-text: #718096;
  --green: #2D8B5F;
  --purple: #6B46C1;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

body {
  font-family: 'Source Sans Pro', sans-serif;
  background: var(--cream);
  color: var(--navy);
  min-height: 100vh;
  display: flex;
}

.skip-link {
  position: absolute;
  top: -40px;
  left: 0;
  background: var(--gold);
  color: var(--navy);
  padding: 8px 16px;
  z-index: 1000;
  font-weight: 600;
  text-decoration: none;
  border-radius: 0 0 8px 0;
}

.skip-link:focus {
  top: 0;
}

.hamburger {
  display: none;
  position: fixed;
  top: 1rem;
  left: 1rem;
  z-index: 1001;
  background: var(--navy);
  border: none;
  border-radius: 8px;
  padding: 12px;
  cursor: pointer;
  flex-direction: column;
  gap: 4px;
}

.hamburger span {
  display: block;
  width: 24px;
  height: 3px;
  background: var(--gold);
  border-radius: 2px;
  transition: transform 0.3s;
}

.sidebar-overlay {
  display: none;
  position: fixed;
  inset: 0;
  background: rgba(0,0,0,0.5);
  z-index: 999;
}

.sidebar {
  width: 280px;
  background: var(--navy);
  padding: 2rem 1rem;
  display: flex;
  flex-direction: column;
  position: fixed;
  height: 100vh;
  overflow-y: auto;
  z-index: 1000;
}

.logo {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.3rem;
  color: var(--gold);
  margin-bottom: 0.5rem;
  text-align: center;
}

.tagline {
  font-size: 0.75rem;
  color: rgba(255,255,255,0.6);
  text-align: center;
  margin-bottom: 2rem;
  font-style: italic;
}

.nav-section {
  margin-bottom: 1.5rem;
}

.nav-label {
  font-size: 0.7rem;
  text-transform: uppercase;
  letter-spacing: 1px;
  color: rgba(255,255,255,0.4);
  margin-bottom: 0.75rem;
  padding-left: 0.5rem;
}

.module-item {
  display: flex;
  align-items: center;
  padding: 0.75rem;
  border-radius: 8px;
  cursor: pointer;
  transition: all 0.2s;
  margin-bottom: 0.25rem;
  border: none;
  background: transparent;
  width: 100%;
  text-align: left;
  font-family: inherit;
  font-size: inherit;
}

.module-item:hover {
  background: rgba(255,255,255,0.1);
}

.module-item.active {
  background: rgba(212, 175, 55, 0.2);
  border-left: 3px solid var(--gold);
}

.module-item.completed .module-number {
  background: var(--green);
}

.module-number {
  width: 28px;
  height: 28px;
  border-radius: 50%;
  background: rgba(255,255,255,0.2);
  display: flex;
  align-items: center;
  justify-content: center;
  font-size: 0.8rem;
  color: white;
  margin-right: 0.75rem;
  flex-shrink: 0;
}

.module-info {
  flex: 1;
  min-width: 0;
}

.module-title {
  font-size: 0.9rem;
  color: white;
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
}

.module-subtitle {
  font-size: 0.7rem;
  color: rgba(255,255,255,0.5);
}

.time-estimate {
  color: var(--teal);
  font-weight: 600;
  font-size: 0.65rem;
}

.main-content {
  flex: 1;
  margin-left: 280px;
  display: flex;
  flex-direction: column;
  min-height: 100vh;
}

.top-bar {
  display: flex;
  justify-content: space-between;
  align-items: center;
  padding: 1rem 2rem;
  background: white;
  border-bottom: 1px solid rgba(0,0,0,0.1);
  flex-wrap: wrap;
  gap: 1rem;
}

.progress-section {
  display: flex;
  align-items: center;
  gap: 1rem;
}

.progress-bar {
  width: 200px;
  height: 8px;
  background: rgba(0,0,0,0.1);
  border-radius: 4px;
  overflow: hidden;
}

.progress-fill {
  height: 100%;
  background: linear-gradient(90deg, var(--gold), var(--purple));
  border-radius: 4px;
  transition: width 0.3s;
}

.progress-text {
  font-size: 0.85rem;
  color: var(--light-text);
}

.course-time {
  font-size: 0.8rem;
  color: var(--light-text);
  padding: 0.25rem 0.75rem;
  background: rgba(107, 70, 193, 0.1);
  border-radius: 12px;
}

.points-display {
  display: flex;
  align-items: center;
  gap: 0.5rem;
  background: linear-gradient(135deg, var(--navy), #2a3a7d);
  color: var(--gold);
  padding: 0.5rem 1rem;
  border-radius: 20px;
  font-weight: 600;
}

.top-actions {
  display: flex;
  gap: 0.5rem;
}

.action-btn {
  padding: 0.5rem 1rem;
  border: 1px solid var(--navy);
  background: transparent;
  border-radius: 6px;
  cursor: pointer;
  font-size: 0.85rem;
  transition: all 0.2s;
}

.action-btn:hover {
  background: var(--navy);
  color: white;
}

.slide-container {
  flex: 1;
  padding: 2rem;
  max-width: 900px;
  margin: 0 auto;
  width: 100%;
}

.slide-title {
  text-align: center;
  padding: 4rem 2rem;
}

.slide-title h1 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 3rem;
  color: var(--navy);
  margin-bottom: 1rem;
}

.slide-title .subtitle {
  font-size: 1.5rem;
  color: var(--purple);
  margin-bottom: 1rem;
}

.slide-title .description {
  font-size: 1.1rem;
  color: var(--light-text);
  max-width: 600px;
  margin: 0 auto;
}

.principle-box {
  background: linear-gradient(135deg, var(--navy), #2a3a7d);
  border-radius: 16px;
  padding: 3rem;
  text-align: center;
  margin: 2rem 0;
}

.principle-box .number {
  font-size: 4rem;
  color: var(--gold);
  font-family: 'Cormorant Garamond', serif;
  line-height: 1;
}

.principle-box .text {
  font-size: 1.8rem;
  color: white;
  font-family: 'Cormorant Garamond', serif;
  margin-top: 1rem;
  font-style: italic;
}

.story-deep {
  background: linear-gradient(135deg, rgba(107,70,193,0.08), rgba(30,39,97,0.12));
  border-left: 4px solid var(--purple);
  border-radius: 0 16px 16px 0;
  padding: 1.5rem;
  margin: 1.5rem 0;
}

.story-label {
  font-size: 0.75rem;
  text-transform: uppercase;
  letter-spacing: 2px;
  color: var(--purple);
  margin-bottom: 0.5rem;
  font-weight: 600;
}

.story-source {
  font-size: 0.8rem;
  color: var(--light-text);
  margin-bottom: 1rem;
  font-style: italic;
}

.timeline {
  position: relative;
  padding-left: 2rem;
  margin: 1.5rem 0;
}

.timeline::before {
  content: '';
  position: absolute;
  left: 0.5rem;
  top: 0;
  bottom: 0;
  width: 2px;
  background: linear-gradient(to bottom, var(--gold), var(--purple), var(--green));
}

.timeline-event {
  position: relative;
  margin-bottom: 1rem;
  padding-left: 1rem;
}

.timeline-event::before {
  content: '';
  position: absolute;
  left: -1.5rem;
  top: 0.5rem;
  width: 10px;
  height: 10px;
  border-radius: 50%;
  background: var(--gold);
}

.timeline-event.crisis::before {
  background: var(--red);
}

.timeline-event.revelation::before {
  background: var(--green);
}

.timeline-year {
  font-weight: 600;
  color: var(--purple);
  font-size: 0.9rem;
}

.timeline-text {
  color: var(--navy);
  font-size: 0.95rem;
  margin-top: 0.25rem;
}

.real-data-box {
  background: rgba(45, 139, 139, 0.1);
  border-radius: 12px;
  padding: 1rem;
  margin-top: 1rem;
}

.real-data-box h4 {
  color: var(--teal);
  font-size: 0.85rem;
  margin-bottom: 0.75rem;
  text-transform: uppercase;
  letter-spacing: 1px;
}

.data-grid {
  display: grid;
  grid-template-columns: repeat(3, 1fr);
  gap: 0.75rem;
}

.data-item {
  text-align: center;
}

.data-label {
  font-size: 0.7rem;
  color: var(--light-text);
  text-transform: uppercase;
}

.data-value {
  font-size: 1rem;
  font-weight: 600;
  color: var(--navy);
}

.hook-text {
  background: linear-gradient(135deg, rgba(212,175,55,0.15), rgba(30,39,97,0.1));
  padding: 1rem;
  border-radius: 8px;
  margin-top: 1rem;
  font-style: italic;
  color: var(--navy);
}

.lesson-gold {
  color: var(--gold);
  font-weight: 600;
  font-style: normal;
  display: block;
  margin-top: 0.5rem;
  padding: 0.75rem;
  background: rgba(30,39,97,0.05);
  border-left: 3px solid var(--gold);
  border-radius: 0 8px 8px 0;
}

.content-box {
  background: white;
  border-radius: 16px;
  padding: 2rem;
  margin: 1.5rem 0;
  box-shadow: 0 2px 8px rgba(0,0,0,0.05);
}

.content-box h2 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.8rem;
  color: var(--navy);
  margin-bottom: 1.5rem;
}

.content-section {
  margin-bottom: 1.5rem;
}

.content-section:last-child {
  margin-bottom: 0;
}

.content-section h3 {
  color: var(--purple);
  font-size: 1.1rem;
  margin-bottom: 0.75rem;
}

.content-section ul {
  list-style: none;
  padding-left: 0;
}

.content-section li {
  padding: 0.5rem 0;
  padding-left: 1.5rem;
  position: relative;
  border-bottom: 1px solid rgba(0,0,0,0.05);
}

.content-section li:last-child {
  border-bottom: none;
}

.content-section li::before {
  content: '‚Üí';
  position: absolute;
  left: 0;
  color: var(--gold);
}

.content-section p {
  color: var(--navy);
  line-height: 1.6;
}

.method-box {
  background: linear-gradient(135deg, rgba(45,139,139,0.08), rgba(30,39,97,0.05));
  border-radius: 16px;
  padding: 2rem;
  margin: 1.5rem 0;
}

.method-label {
  font-size: 0.7rem;
  text-transform: uppercase;
  letter-spacing: 2px;
  color: var(--teal);
  margin-bottom: 0.5rem;
}

.method-box h2 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.6rem;
  color: var(--navy);
  margin-bottom: 1.5rem;
}

.method-section {
  margin-bottom: 1.25rem;
  padding-bottom: 1.25rem;
  border-bottom: 1px solid rgba(0,0,0,0.1);
}

.method-section:last-child {
  border-bottom: none;
  margin-bottom: 0;
  padding-bottom: 0;
}

.method-section h3 {
  color: var(--teal);
  font-size: 1rem;
  margin-bottom: 0.5rem;
}

.method-section p {
  color: var(--navy);
  line-height: 1.6;
  white-space: pre-line;
}

.decision-tree {
  background: white;
  border-radius: 16px;
  padding: 2rem;
  margin: 1.5rem 0;
  box-shadow: 0 4px 16px rgba(0,0,0,0.08);
}

.decision-tree h2 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.6rem;
  color: var(--navy);
  margin-bottom: 0.5rem;
}

.decision-situation {
  background: rgba(107,70,193,0.1);
  padding: 1rem;
  border-radius: 8px;
  margin-bottom: 1.5rem;
  font-size: 0.95rem;
  color: var(--navy);
}

.decision-question {
  font-weight: 600;
  color: var(--purple);
  margin-bottom: 1rem;
  font-size: 1.1rem;
}

.decision-branches {
  display: flex;
  flex-direction: column;
  gap: 0.75rem;
}

.decision-branch {
  padding: 1rem;
  background: rgba(0,0,0,0.03);
  border: 2px solid transparent;
  border-radius: 8px;
  cursor: pointer;
  transition: all 0.2s;
  text-align: left;
  font-family: inherit;
  font-size: 0.95rem;
}

.decision-branch:hover {
  border-color: var(--purple);
  background: rgba(107,70,193,0.05);
}

.decision-outcome {
  padding: 1.5rem;
  border-radius: 12px;
  margin-top: 1rem;
}

.decision-outcome.success {
  background: linear-gradient(135deg, rgba(45,139,95,0.15), rgba(45,139,95,0.05));
  border-left: 4px solid var(--green);
}

.decision-outcome.danger {
  background: linear-gradient(135deg, rgba(191,45,45,0.15), rgba(191,45,45,0.05));
  border-left: 4px solid var(--red);
}

.decision-outcome.partial {
  background: linear-gradient(135deg, rgba(212,175,55,0.15), rgba(212,175,55,0.05));
  border-left: 4px solid var(--gold);
}

.outcome-title {
  font-weight: 600;
  font-size: 1.1rem;
  margin-bottom: 0.5rem;
}

.success .outcome-title { color: var(--green); }
.danger .outcome-title { color: var(--red); }
.partial .outcome-title { color: var(--gold); }

.outcome-text {
  color: var(--navy);
  margin-bottom: 1rem;
  line-height: 1.6;
}

.outcome-lesson {
  font-style: italic;
  color: var(--light-text);
  padding-top: 0.75rem;
  border-top: 1px solid rgba(0,0,0,0.1);
}

.tree-controls {
  display: flex;
  gap: 0.5rem;
  margin-top: 1rem;
}

.tree-btn {
  padding: 0.5rem 1rem;
  border: 1px solid var(--navy);
  background: transparent;
  border-radius: 6px;
  cursor: pointer;
  font-size: 0.85rem;
  transition: all 0.2s;
}

.tree-btn:hover {
  background: var(--navy);
  color: white;
}

.quiz-container {
  background: white;
  border-radius: 16px;
  padding: 2rem;
  margin: 1.5rem 0;
  box-shadow: 0 4px 16px rgba(0,0,0,0.08);
}

.quiz-question {
  font-size: 1.1rem;
  color: var(--navy);
  margin-bottom: 1.5rem;
  font-weight: 500;
}

.quiz-options {
  display: flex;
  flex-direction: column;
  gap: 0.75rem;
}

.quiz-option {
  padding: 1rem;
  background: rgba(0,0,0,0.03);
  border: 2px solid transparent;
  border-radius: 8px;
  cursor: pointer;
  transition: all 0.2s;
  text-align: left;
  font-family: inherit;
  font-size: 0.95rem;
}

.quiz-option:hover {
  border-color: var(--purple);
}

.quiz-option.selected {
  border-color: var(--navy);
  background: rgba(30,39,97,0.05);
}

.quiz-option.correct {
  border-color: var(--green);
  background: rgba(45,139,95,0.1);
}

.quiz-option.incorrect {
  border-color: var(--red);
  background: rgba(191,45,45,0.1);
}

.quiz-feedback {
  margin-top: 1rem;
  padding: 1rem;
  border-radius: 8px;
  display: none;
}

.quiz-feedback.show {
  display: block;
}

.quiz-feedback.correct {
  background: rgba(45,139,95,0.1);
  border-left: 4px solid var(--green);
}

.quiz-feedback.incorrect {
  background: rgba(191,45,45,0.1);
  border-left: 4px solid var(--red);
}

.nav-buttons {
  display: flex;
  justify-content: space-between;
  padding: 1rem 2rem;
  background: white;
  border-top: 1px solid rgba(0,0,0,0.1);
}

.nav-btn {
  display: flex;
  align-items: center;
  gap: 0.5rem;
  padding: 0.75rem 1.5rem;
  border: none;
  border-radius: 8px;
  cursor: pointer;
  font-size: 1rem;
  font-weight: 600;
  transition: all 0.2s;
}

.nav-btn.prev {
  background: rgba(0,0,0,0.05);
  color: var(--navy);
}

.nav-btn.prev:hover {
  background: rgba(0,0,0,0.1);
}

.nav-btn.next {
  background: linear-gradient(135deg, var(--purple), #8B5CF6);
  color: white;
}

.nav-btn.next:hover {
  transform: translateX(4px);
}

.nav-btn:disabled {
  opacity: 0.5;
  cursor: not-allowed;
}

.badge-notification {
  position: fixed;
  bottom: 2rem;
  right: 2rem;
  background: linear-gradient(135deg, var(--navy), #2a3a7d);
  border-radius: 16px;
  padding: 1rem 1.5rem;
  display: flex;
  align-items: center;
  gap: 1rem;
  box-shadow: 0 8px 32px rgba(0,0,0,0.3);
  z-index: 3000;
  transform: translateY(100px);
  opacity: 0;
  transition: all 0.5s cubic-bezier(0.34, 1.56, 0.64, 1);
}

.badge-notification.show {
  transform: translateY(0);
  opacity: 1;
}

.badge-icon {
  width: 48px;
  height: 48px;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-size: 1.5rem;
  box-shadow: 0 4px 12px rgba(0,0,0,0.2);
}

.badge-info {
  color: white;
}

.badge-earned {
  font-size: 0.7rem;
  text-transform: uppercase;
  letter-spacing: 1px;
  color: var(--gold);
  margin-bottom: 0.25rem;
}

.badge-name {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.2rem;
  font-weight: 600;
}

.badge-grid {
  display: grid;
  grid-template-columns: repeat(auto-fill, minmax(140px, 1fr));
  gap: 1rem;
  margin-top: 1rem;
}

.badge-card {
  background: white;
  border-radius: 12px;
  padding: 1rem;
  text-align: center;
  border: 2px solid transparent;
  transition: all 0.3s;
}

.badge-card.earned {
  border-color: var(--gold);
  box-shadow: 0 4px 12px rgba(212, 175, 55, 0.2);
}

.badge-card.locked {
  opacity: 0.5;
  filter: grayscale(1);
}

.formula-box {
  background: rgba(30, 39, 97, 0.08);
  border-radius: 8px;
  padding: 1rem;
  margin: 1rem 0;
  font-family: 'Courier New', monospace;
  text-align: center;
  color: var(--navy);
  font-size: 1.1rem;
}

.performance-metric {
  display: flex;
  align-items: center;
  gap: 1rem;
  padding: 1rem;
  background: rgba(107, 70, 193, 0.08);
  border-radius: 8px;
  margin: 0.75rem 0;
}

.metric-value {
  font-size: 2rem;
  font-weight: 700;
  color: var(--purple);
  min-width: 80px;
  text-align: center;
}

.metric-info h4 {
  color: var(--navy);
  margin-bottom: 0.25rem;
}

.metric-info p {
  font-size: 0.85rem;
  color: var(--light-text);
}

@media (max-width: 768px) {
  .hamburger {
    display: flex;
  }

  .sidebar {
    transform: translateX(-100%);
    transition: transform 0.3s;
  }

  .sidebar.open {
    transform: translateX(0);
  }

  .sidebar-overlay.show {
    display: block;
  }

  .main-content {
    margin-left: 0;
  }

  .slide-title h1 {
    font-size: 2rem;
  }

  .data-grid {
    grid-template-columns: 1fr 1fr;
  }

  .top-bar {
    padding: 1rem;
  }

  .progress-bar {
    width: 120px;
  }
}

@media (max-width: 480px) {
  .sidebar {
    width: 100%;
  }

  .slide-container {
    padding: 1rem;
  }

  .story-deep, .method-box, .content-box {
    padding: 1rem;
  }

  .data-grid {
    grid-template-columns: 1fr 1fr;
  }

  .top-actions {
    width: 100%;
    justify-content: center;
  }
}

    /* Focus-visible styles for keyboard navigation */
    :focus-visible {
      outline: 2px solid var(--gold, #D4AF37);
      outline-offset: 2px;
    }

    :focus:not(:focus-visible) {
      outline: none;
    }

    button:focus-visible,
    a:focus-visible,
    [role="button"]:focus-visible,
    input:focus-visible,
    select:focus-visible,
    textarea:focus-visible {
      outline: 2px solid var(--gold, #D4AF37);
      outline-offset: 2px;
      box-shadow: 0 0 0 4px rgba(212, 175, 55, 0.3);
    }

    /* Screen Reader Only */
    .sr-only {
      position: absolute;
      width: 1px;
      height: 1px;
      padding: 0;
      margin: -1px;
      overflow: hidden;
      clip: rect(0, 0, 0, 0);
      white-space: nowrap;
      border: 0;
    }

    @media (prefers-reduced-motion: reduce) {
      *, *::before, *::after {
        animation-duration: 0.01ms !important;
        animation-iteration-count: 1 !important;
        transition-duration: 0.01ms !important;
        scroll-behavior: auto !important;
      }
    }
  </style>
</head>
<body>
<a class="skip-link" href="#main-content">Skip to main content</a>
<button aria-expanded="false" aria-label="Toggle navigation menu" class="hamburger">
<span></span>
<span></span>
<span></span>
</button>
<div class="sidebar-overlay"></div>
<nav aria-label="Moduli del corso" class="sidebar" role="navigation">
<a href="index.html" onmouseout="this.style.color='rgba(212,175,55,0.7)'" onmouseover="this.style.color='#D4AF37'" style="display:block;font-size:0.7rem;color:rgba(212,175,55,0.7);text-decoration:none;margin-bottom:0.5rem;padding:0.5rem 1rem 0;">‚Üê Course Library</a>
<div class="logo">Prognostic Reviews</div>
<div class="tagline">Predicting Patient Futures</div>
<div class="nav-section">
<div class="nav-label">Modules</div>
<div id="module-nav"></div>
</div>
</nav>
<main class="main-content" id="main-content">
<div class="top-bar">
<div class="progress-section">
<div class="progress-bar">
<div class="progress-fill" id="progress-fill" style="width: 0%"></div>
</div>
<span class="progress-text" id="progress-text">0% Complete</span>
</div>
<div class="course-time">
<span id="total-time">5h 40m total</span>
</div>
<div class="points-display">
<span id="points-display">0</span> XP
      </div>
<div class="top-actions">
<button class="action-btn" onclick="openBadges()">üèÜ Badges</button>
<button class="action-btn" onclick="openGlossary()">Glossary</button>
</div>
</div>
<div class="slide-container" id="slide-container"></div>
<div aria-live="polite" class="sr-only" id="slide-announce"></div>
<div class="nav-buttons">
<button class="nav-btn prev" id="prev-btn" onclick="prevSlide()">
<span>‚Üê</span> Previous
      </button>
<button class="nav-btn next" id="next-btn" onclick="nextSlide()">
        Next <span>‚Üí</span>
</button>
</div>
</main>
<script>
const STORAGE_KEY = 'prognostic-reviews-course-progress';

let currentModule = 0;
let currentSlide = 0;
let gameState = {
  points: 0,
  earnedBadges: [],
  modulesCompleted: [],
  decisionTrees: {}
};

// Badge Definitions
const BADGES = {
  'model-builder': { name: 'Model Builder', icon: 'üîß', color: '#6B46C1', requirement: 'Modulo completo di sviluppo del modello' },
  'validation-expert': { name: 'Validation Expert', icon: '‚úÖ', color: '#2D8B5F', requirement: 'Modulo di convalida completo' },
  'calibration-master': { name: 'Calibration Master', icon: 'üìä', color: '#2D8B8B', requirement: 'Esercizi di calibrazione completi' },
  'tripod-scholar': { name: 'TRIPOD Scholar', icon: 'üìù', color: '#D4AF37', requirement: 'Modulo di reporting completo' },
  'decision-analyst': { name: 'Decision Analyst', icon: 'üìà', color: '#BF2D2D', requirement: 'Modulo completo sulle curve decisionali' },
  'story-collector': { name: 'Story Collector', icon: 'üìö', color: '#1e2761', requirement: 'Leggi tutti i casi studio' },
  'tree-navigator': { name: 'Tree Navigator', icon: 'üå≥', color: '#2D8B5F', requirement: 'Completa 15 alberi decisionali' },
  'prognosis-master': { name: 'Prognosis Master', icon: 'üéì', color: '#6B46C1', requirement: 'Completa l\'intero corso' },
  'penalization-pro': { name: 'Penalization Pro', icon: 'üéØ', color: '#8B5CF6', requirement: 'Master LASSO/Ridge content' },
  'communicator': { name: 'Patient Communicator', icon: 'üí¨', color: '#EC4899', requirement: 'Learn uncertainty communication' },
  'skeptic': { name: 'AI Skeptic', icon: 'ü§ñ', color: '#F59E0B', requirement: 'Modulo completo ML vs regressione' },
  'implementer': { name: 'Implementation Expert', icon: 'üè•', color: '#10B981', requirement: 'Modulo di implementazione completo' }
};

const modules = [
  {
    id: 0,
    title: "The Opening",
    subtitle: "Why Prognosis Matters",
    principle: null,
    estimatedTime: "15 min",
    slides: [
      {
        type: 'title',
        content: {
          title: "Prognostic Reviews",
          subtitle: "Predicting Patient Futures",
          text: "Impara a valutare e costruire modelli di previsione attraverso le storie di punteggi che hanno salvato vite umane e algoritmi che hanno promesso troppo."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "LA FONDAZIONE: FRAMINGHAM ‚Äî QUANDO I MEDICI IMPARANO A VEDERE IL FUTURO",
          source: "Framingham Heart Study 1948-present | Wilson 1998 | Circulation",
          timeline: [
            { year: "1948", text: "Framingham Heart Study begins in Massachusetts. 5,209 adults enrolled. No one knows what causes heart disease. Cholesterol is just a chemical.", type: "normal" },
            { year: "1961", text: "First major finding: high cholesterol, high blood pressure, and smoking predict heart attacks. The concept of 'risk factors' is born.", type: "revelation" },
            { year: "1976", text: "Framingham Risk Score developed: age, sex, cholesterol, BP, smoking, diabetes combined into one number. Doctors can now QUANTIFY a patient's 10-year risk.", type: "revelation" },
            { year: "1998", text: "Updated Framingham Risk Score published. C-statistic 0.76-0.79. Widely adopted. Millions of statin decisions based on this score.", type: "normal" },
            { year: "2000s", text: "External validation shows Framingham overestimates risk in some populations (UK, Europe, Asia). Recalibration needed. One model doesn't fit all.", type: "crisis" },
            { year: "Legacy", text: "Framingham proved prognosis is POSSIBLE and USEFUL. But it also showed: models must be validated, calibration matters, and context is everything.", type: "revelation" }
          ],
          realData: {
            endpoint: "10-year cardiovascular disease risk",
            model: "Framingham Risk Score",
            discrimination: "C-statistic 0.76-0.79",
            impact: "Guides statin therapy for millions worldwide"
          },
          hook: "THE HOOK: Before Framingham, doctors guessed who would have heart attacks. After Framingham, they could calculate it. This course teaches you to evaluate such calculations ‚Äî to know when a prognostic model helps patients and when it's just mathematical theater."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è KEY INSIGHT: Prognostic models translate uncertainty into numbers. A patient asking 'What are my chances?' deserves more than 'It depends.' But those numbers must be ACCURATE (calibration), DISCRIMINATING (separate high from low risk), and USEFUL (change decisions). A model can fail any of these ‚Äî and often does."
        }
      },
      {
        type: 'content',
        content: {
          title: "What Is Prognostic Research?",
          sections: [
            {
              heading: "Prognosis vs Other Research Types:",
              items: [
                "DIAGNOSTIC: Who HAS the disease NOW? (presence/absence)",
                "ETIOLOGIC: What CAUSES the disease? (causation)",
                "THERAPEUTIC: What TREATS the disease? (intervention effects)",
                "PROGNOSTIC: What WILL HAPPEN to the patient? (future outcomes)"
              ]
            },
            {
              heading: "Why Prognosis Matters:",
              items: [
                "Treatment decisions: Should this patient get aggressive therapy?",
                "Patient counseling: What should I expect?",
                "Resource allocation: Who needs intensive monitoring?",
                "Trial design: Enriching populations for higher event rates",
                "Quality measurement: Risk-adjusted outcomes"
              ]
            },
            {
              heading: "The Fundamental Question:",
              text: "Dato ci√≤ che sappiamo ORA di un paziente, qual √® la probabilit√† di un RISULTATO specifico in un ORIZZONTE TEMPORALE definito?"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "The Seven Principles of Prognostic Modeling",
          sections: [
            {
              heading: "Your Guide Through This Course:",
              items: [
                "1. \\\"La previsione non √® causalit√†\\\" ‚Äî Non √® necessario che i predittori siano cause",
                "2. \"A model is only as good as its validation\" ‚Äî Development means nothing without testing",
                "3. \"Discrimination is not enough\" ‚Äî A model must also be calibrated",
                "4. \"More predictors is not better\" ‚Äî Overfitting destroys generalizability",
                "5. \\\"La popolazione definisce la previsione\\\" - I modelli non viaggiano liberamente",
                "6. \"Clinical utility trumps statistics\" ‚Äî Good numbers don't guarantee good decisions",
                "7. \"Transparency enables trust\" ‚Äî TRIPOD and reporting standards matter"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'prognosis-vs-diagnosis',
          title: "Prognosis or Diagnosis?",
          situation: "Classify each clinical question as prognostic, diagnostic, etiologic, or therapeutic.",
          nodes: {
            start: {
              question: "DOMANDA 1: 'Questo paziente con dolore toracico ha un'embolia polmonare?'",
              branches: [
                { text: "Prognostic ‚Äî predicting future outcome", nextNode: "q1_wrong" },
                { text: "Diagnostic ‚Äî determining current disease state", nextNode: "q1_correct" }
              ]
            },
            q1_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "This is diagnostic!",
              text: "The question is about what the patient HAS right now (PE or not), not what will happen in the future. Diagnosis = current state. Prognosis = future outcome.",
              lesson: "Domande diagnostiche: il paziente HA la condizione X? Domande prognostiche: cosa accadr√† al paziente?"
            },
            q1_correct: {
              situation: "Corretto! La domanda riguarda lo stato attuale della malattia, non l‚Äôesito futuro.",
              question: "DOMANDA 2: \"Qual √® la probabilit√† di sopravvivenza di questo paziente in terapia intensiva fino alla dimissione dall'ospedale?\"",
              branches: [
                { text: "Prognostic ‚Äî predicting future survival", nextNode: "q2_correct" },
                { text: "Diagnostic ‚Äî assessing current severity", nextNode: "q2_wrong" }
              ]
            },
            q2_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Vicino, ma questo √® prognostico",
              text: "Sebbene la valutazione della gravit√† possa fornire informazioni sulla previsione, la DOMANDA riguarda un risultato FUTURO (sopravvivenza alla dimissione). L‚Äôorizzonte temporale lo rende prognostico.",
              lesson: "Se la domanda riguarda un punto temporale futuro (sopravviver√†, si svilupper√†, si ripresenter√†), √® prognostica."
            },
            q2_correct: {
              situation: "Correct! Survival to discharge is a future outcome ‚Äî classic prognosis.",
              question: "QUESTION 3: 'Does smoking cause lung cancer?'",
              branches: [
                { text: "Prognostic ‚Äî smoking predicts cancer", nextNode: "q3_prog_wrong" },
                { text: "Eziologico: chiedere informazioni sulla causalit√†", nextNode: "q3_correct" }
              ]
            },
            q3_prog_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Il fumo √® predittivo, ma non √® questo il problema",
              text: "Il fumo predice il cancro ai polmoni e potrebbe essere un modello prognostico. Ma la domanda √® se il fumo CAUSA il cancro: questo √® eziologico. La prognosi utilizza predittori indipendentemente dalla causa.",
              lesson: "Prognostic models can include non-causal predictors. Etiologic research specifically asks about CAUSATION."
            },
            q3_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Exactly right!",
              text: "La domanda riguarda la CAUSA: il fumo provoca il cancro? Ci√≤ richiede metodi di inferenza causale (controllo confondente, temporalit√†, ecc.). I modelli prognostici possono utilizzare il fumo come predittore SENZA dimostrare che sia causale.",
              lesson: "Prediction ‚â† Causation. A prognostic model can include age, sex, biomarkers ‚Äî none 'cause' the outcome, but all predict it."
            }
          }
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è THE WARNING: As you learn prognostic methods, remember: every model is wrong, but some are useful. Framingham changed medicine. But poorly validated models have also caused harm ‚Äî allocating resources wrongly, giving false reassurance, or creating false alarm. The question isn't whether a model exists, but whether it WORKS and HELPS."
        }
      }
    ]
  },
  {
    id: 1,
    title: "The Factors",
    subtitle: "Studi sui fattori prognostici",
    principle: 0,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "La previsione non √® causalit√†"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE BIOMARKER TRAP: TROPONIN ‚Äî WHEN A PREDICTOR BECAME A TARGET",
          source: "Multiple troponin trials | JAMA, NEJM | High-sensitivity assays",
          timeline: [
            { year: "1990s", text: "Cardiac troponin identified as marker of myocardial damage. Elevated troponin strongly predicts death in ACS patients. OR for death: 3-5x.", type: "normal" },
            { year: "2000s", text: "Troponin becomes standard for ACS diagnosis AND prognosis. Higher levels = worse outcomes. Dose-response relationship clear.", type: "normal" },
            { year: "The Idea", text: "'If high troponin predicts bad outcomes, we should treat patients with high troponin more aggressively.' Trials test intensive therapy in troponin-positive patients.", type: "normal" },
            { year: "The Results", text: "FRISC-II, TACTICS-TIMI 18: Invasive strategy helps troponin-positive patients. Success? Or just treating sicker patients?", type: "revelation" },
            { year: "The Trap", text: "La troponina PREVEDE gli esiti ma non li CAUSA. Abbassare la troponina (il numero) non migliora i risultati. La troponina √® un MARKER di danno, non un bersaglio del trattamento.", type: "crisis" },
            { year: "Lesson", text: "I fattori prognostici possono guidare QUALI pazienti trattare in modo intensivo. Ma trattare IL FATTORE (abbassando il numero) non aiuta a meno che il fattore non sia causale E modificabile.", type: "revelation" }
          ],
          realData: {
            endpoint: "Mortality, reinfarction",
            factor: "Troponin elevation",
            effect: "OPPURE 3-5 per esiti avversi",
            lesson: "Predicts outcome; not a treatment target"
          },
          hook: "THE HOOK: Troponin is a superb prognostic factor. But trying to 'lower troponin' makes no sense ‚Äî it's smoke, not fire. The first principle of prognostic factors: PREDICTION does not equal CAUSATION. A factor can be a perfect predictor and a useless treatment target."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è KEY INSIGHT: i fattori prognostici sono variabili associate ai risultati futuri. Non √® necessario che siano CAUSALI. L‚Äôet√† predice la mortalit√†, ma non √® possibile modificare l‚Äôet√†. I marcatori tumorali predicono la recidiva, ma abbassare i marcatori non cura il cancro. Distinguere i fattori PROGNOSTICI dagli obiettivi TERAPEUTICI."
        }
      },
      {
        type: 'content',
        content: {
          title: "Che cos'√® uno studio sui fattori prognostici?",
          sections: [
            {
              heading: "Definition:",
              items: [
                "Studio che esamina se un fattore √® associato a un risultato clinico",
                "Usually in patients with a specific condition (inception cohort)",
                "Factor measured at baseline; outcome measured later",
                "Adjust for other known prognostic factors to assess INDEPENDENT contribution"
              ]
            },
            {
              heading: "Types of Prognostic Factors:",
              items: [
                "DEMOGRAPHIC: Age, sex, race/ethnicity",
                "CLINICAL: Disease stage, comorbidities, functional status",
                "BIOMARKERS: Lab values, imaging findings, genetic markers",
                "PATIENT-REPORTED: Quality of life, symptoms, preferences"
              ]
            },
            {
              heading: "Key Distinction:",
              text: "Fattore prognostico ‚â† Fattore di rischio. I fattori di rischio sono studiati in popolazioni sane (chi sviluppa la malattia?). I fattori prognostici vengono studiati nei pazienti CON malattia (cosa succede loro?)."
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: DISEGNO DI STUDIO DEI FATTORI PROGNOSTICI",
          title: "Come studiare i fattori prognostici",
          sections: [
            {
              heading: "1. Define the Population (Inception Cohort):",
              text: "‚Ä¢ Start point: Diagnosis, treatment initiation, or clinical event\n‚Ä¢ All patients should be at SIMILAR point in disease course\n‚Ä¢ Avoid prevalent cohorts (survivors already selected)"
            },
            {
              heading: "2. Measure the Factor at Baseline:",
              text: "‚Ä¢ Before outcome can occur\n‚Ä¢ Standardized measurement\n‚Ä¢ Handle missing data transparently"
            },
            {
              heading: "3. Define the Outcome:",
              text: "‚Ä¢ Clinically meaningful (death, recurrence, functional status)\n‚Ä¢ Fixed time horizon (5-year survival, 30-day readmission)\n‚Ä¢ Objective measurement or adjudication"
            },
            {
              heading: "4. Adjust for Confounders:",
              text: "‚Ä¢ Altri fattori prognostici accertati ‚Ä¢ Variabili che potrebbero spiegare l'associazione ‚Ä¢ Utilizzare i DAG per identificare i set di aggiustamento"
            },
            {
              heading: "5. Report Effect Sizes with Uncertainty:",
              text: "‚Ä¢ Hazard ratios, odds ratios, or risk ratios with 95% CIs\n‚Ä¢ Continuous factors: per-unit change or meaningful increments\n‚Ä¢ Avoid arbitrary dichotomization"
            }
          ]
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE FALSE PROMISE: PSA VELOCITY ‚Äî WHEN A PROGNOSTIC FACTOR WASN'T",
          source: "Vickers et al. JNCI 2011 | PSA velocity meta-analysis | Prostate cancer",
          timeline: [
            { year: "1990s", text: "PSA velocity (rate of PSA rise) proposed as prostate cancer predictor. Faster rise = more aggressive cancer. Made biological sense.", type: "normal" },
            { year: "2000s", text: "Studi osservazionali mostrano che la velocit√† del PSA predice la mortalit√†. Le linee guida incorporano la velocit√† nelle decisioni sulla biopsia. Interi percorsi clinici costruiti attorno ad esso.", type: "normal" },
            { year: "2007", text: "Systematic review by Vickers: When ADJUSTING FOR BASELINE PSA, velocity adds NO prognostic information. Velocity was confounded by baseline level.", type: "crisis" },
            { year: "The Math", text: "High velocity often means high PSA. High PSA predicts outcomes. Velocity appeared predictive only because it correlated with level. Classic confounding.", type: "revelation" },
            { year: "Aftermath", text: "Guidelines revised. Velocity de-emphasized. Years of clinical practice based on a 'prognostic factor' that wasn't independently prognostic.", type: "crisis" },
            { year: "Lesson", text: "Chiediti sempre: questo fattore aggiunge informazioni OLTRE ci√≤ che gi√† sappiamo? Il valore prognostico indipendente richiede un aggiustamento per fattori stabiliti.", type: "revelation" }
          ],
          realData: {
            endpoint: "Prostate cancer mortality",
            factor: "PSA velocity (unadjusted)",
            effect: "HR ~2,0 per alto vs basso",
            adjusted: "HR ~1.0 when adjusted for baseline PSA"
          },
          hook: "THE HOOK: PSA velocity was used for years before anyone checked if it added information beyond baseline PSA. It didn't. The lesson: A factor that CORRELATES with the outcome isn't necessarily an INDEPENDENT prognostic factor. Always adjust for what you already know."
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'prognostic-factor-assessment',
          title: "Questo fattore √® veramente prognostico?",
          situation: "A study claims that serum ferritin predicts mortality in heart failure patients. HR 2.1 (95% CI 1.5-2.9) for high vs low ferritin. The study adjusted for age and sex only. Known prognostic factors in heart failure include: ejection fraction, BNP, renal function, NYHA class.",
          nodes: {
            start: {
              question: "Qual √® la tua prima preoccupazione riguardo questo studio?",
              branches: [
                { text: "L'HR di 2,1 √® troppo grande per essere credibile", nextNode: "hr_concern" },
                { text: "L'aggiustamento solo per et√† e sesso √® insufficiente", nextNode: "adjustment_correct" },
                { text: "Ferritin isn't biologically plausible", nextNode: "biology_concern" }
              ]
            },
            hr_concern: {
              type: 'outcome',
              outcome: 'partial',
              title: "HR 2.1 isn't inherently implausible",
              text: "Le dimensioni dell'effetto di 2,0 sono comuni per forti fattori prognostici (troponina, BNP). Il problema non √® la dimensione dell‚Äôeffetto, ma se l‚Äôeffetto PERSISTE dopo un adeguato aggiustamento. Un fattore con HR 2.0 non aggiustato potrebbe avere HR 1.0 aggiustato.",
              lesson: "Judge prognostic factors by their adjusted effects, not by whether raw effects 'seem' too big."
            },
            adjustment_correct: {
              situation: "Esattamente! Senza aggiustamento per EF, BNP, funzione renale e classe NYHA, non sappiamo se la ferritina sia INDIPENDENTEmente prognostica o semplicemente correlata con questi fattori stabiliti.",
              question: "Una nuova analisi aggiusta per tutti i fattori principali. L'HR della ferritina scende da 2,1 a 1,3 (0,95-1,7). Cosa concludi?",
              branches: [
                { text: "Ferritin is still prognostic ‚Äî HR > 1.0", nextNode: "still_prognostic_wrong" },
                { text: "Ferritin adds minimal independent information ‚Äî CI includes 1.0", nextNode: "minimal_info_correct" },
                { text: "Lo studio era sbagliato: la ferritina √® inutile", nextNode: "useless_too_strong" }
              ]
            },
            biology_concern: {
              type: 'outcome',
              outcome: 'partial',
              title: "Biology matters, but don't require it",
              text: "Biological plausibility strengthens causal claims. But prognostic factors don't need to be causal! Age predicts mortality without 'causing' it. Ferritin could be a marker of inflammation, iron status, or comorbidity ‚Äî any of which might explain prediction.",
              lesson: "Per PROGNOSI: la plausibilit√† √® gradevole ma non richiesta. Per l'EZIOLOGIA: la plausibilit√† √® essenziale."
            },
            still_prognostic_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Guarda l'intervallo di confidenza!",
              text: "HR 1.3 con 95% CI 0.95-1.7 INCLUDE 1.0. Ci√≤ significa che non possiamo escludere alcuna associazione. La stima puntuale √® scesa del 60% dopo l'aggiustamento (da 2,1 a 1,3), suggerendo che la maggior parte dell'\"effetto\" era confuso.",
              lesson: "Always report and interpret confidence intervals. A point estimate means nothing without uncertainty."
            },
            minimal_info_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct interpretation!",
              text: "L'attenuazione del 60% (2,1 ‚Üí 1,3) suggerisce che la ferritina stava in gran parte catturando la variazione di altri fattori (probabilmente funzione renale e infiammazione). L'IC ora include 1.0. La ferritina probabilmente aggiunge poche informazioni prognostiche indipendenti nell'insufficienza cardiaca.",
              lesson: "This pattern (strong unadjusted, weak adjusted) is extremely common. Always demand properly adjusted analyses before accepting a 'new prognostic factor.'"
            },
            useless_too_strong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Too strong a conclusion",
              text: "The adjusted HR is 1.3 ‚Äî not 1.0. Ferritin MIGHT have modest independent prognostic value; we're just uncertain. It's not 'useless' ‚Äî it's 'not proven useful beyond existing factors.' A larger study might clarify.",
              lesson: "Assenza di evidenza ‚â† evidenza di assenza. Ma non dovremmo utilizzare i fattori clinicamente finch√© non viene stabilito un valore prognostico indipendente."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A biomarker strongly predicts mortality (HR 4.0, p<0.001) but is NOT on the causal pathway to death. This biomarker could still be useful for:",
          options: [
            { id: 'a', text: "Sviluppare un trattamento che riduca il biomarcatore", correct: false },
            { id: 'b', text: "Risk stratification to guide treatment intensity", correct: true },
            { id: 'c', text: "Dimostrare che il biomarcatore causa la morte", correct: false },
            { id: 'd', text: "Replacing other prognostic factors in clinical assessment", correct: false }
          ],
          explanation: "I predittori non causali sono inutili come obiettivi del trattamento (abbassarli non aiuter√†), ma POSSONO essere utili per la stratificazione del rischio. Se un biomarcatore identifica pazienti ad alto rischio, i medici possono trattarli in modo pi√π aggressivo, anche se il biomarcatore stesso non √® l'obiettivo del trattamento."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "REAL-WORLD CASE: THE PSA SCREENING CONTROVERSY ‚Äî EXCELLENT DISCRIMINATION, TERRIBLE UTILITY",
          source: "US Preventive Services Task Force | ERSPC Trial | Prostate cancer screening debates",
          timeline: [
            { year: "1986", text: "L'antigene prostatico specifico (PSA) √® approvato dalla FDA per il monitoraggio del cancro alla prostata. Presto adottato per lo SCREENING negli uomini sani. La logica: un PSA elevato predice il cancro alla prostata.", type: "normal" },
            { year: "1990s", text: "PSA screening becomes routine. Millions of men tested annually. Prostate cancer diagnoses skyrocket. 'Early detection saves lives' becomes dogma.", type: "normal" },
            { year: "The Problem", text: "PSA is elevated in prostate cancer ‚Äî but also in benign prostatic hyperplasia, prostatitis, even vigorous cycling. PSA discriminates cancer from no-cancer... imperfectly.", type: "crisis" },
            { year: "Overdiagnosis", text: "Many detected cancers would NEVER have caused symptoms or death. These indolent tumors were treated anyway: surgery, radiation, hormones. Men suffered incontinence, impotence, anxiety ‚Äî for cancers that didn't need treatment.", type: "crisis" },
            { year: "2012", text: "L'USPSTF raccomanda CONTRO lo screening di routine del PSA. I danni (sovradiagnosi, sovratrattamento) superavano i benefici. Un fattore prognostico con eccellente discriminazione ma danno clinico netto.", type: "revelation" },
            { year: "Lesson", text: "PSA correctly identifies men with prostate cancer. But not all prostate cancers are equal. Detecting harmless cancers and treating them aggressively causes MORE harm than missing them. <span class='lesson-gold'>THE LESSON: A prognostic factor can have excellent discrimination yet terrible clinical utility. The question isn't just 'does it predict?' but 'does acting on the prediction help patients?'</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "Prostate cancer detection",
            factor: "PSA (prostate-specific antigen)",
            discrimination: "Statistica C ~0,70 per il rilevamento del cancro",
            problem: "Overdiagnosis and overtreatment of indolent cancers"
          },
          hook: "THE HOOK: PSA is the canonical example of a good prognostic factor that causes harm in practice. It PREDICTS prostate cancer. The prediction is ACCURATE. But acting on that prediction ‚Äî biopsying, treating, worrying ‚Äî often hurts men more than the cancer would have. Clinical utility requires more than accurate prediction."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You now understand prognostic factor studies. Key lessons: (1) Factors must be independently predictive after adjustment; (2) Prediction ‚â† causation; (3) Unadjusted associations are often confounded; (4) Non-causal predictors can still guide treatment decisions by identifying high-risk patients."
        }
      }
    ]
  },
  {
    id: 2,
    title: "The Models",
    subtitle: "Prediction Model Development",
    principle: 1,
    estimatedTime: "40 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "A model is only as good as its validation"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE OVERFIT: DUKE CANCER GENOMICS - QUANDO LE PREVISIONI PERFETTE ERANO PERFETTAMENTE SBAGLIATE",
          source: "Baggerly & Coombes 2009 | Nature Medicine | Duke scandal",
          timeline: [
            { year: "2006", text: "Duke researchers publish genomic signatures that 'perfectly' predict chemotherapy response. Lancet, Nature Medicine. C-statistics near 1.0. Clinical trials launched.", type: "normal" },
            { year: "2007-08", text: "Biostatisticians Baggerly & Coombes try to reproduce results. Find errors: mislabeled samples, wrong gene names, data inconsistencies. Report concerns.", type: "crisis" },
            { year: "2009", text: "Duke respinge le preoccupazioni. Gli studi continuano ad arruolare pazienti. \"I risultati parlano da soli.\" L'indagine interna non ha riscontrato problemi.", type: "crisis" },
            { year: "2010", text: "NCI pauses trials. External audit confirms systematic errors. Lead researcher Potti found to have fabricated credentials. Trials terminated. Patients harmed.", type: "crisis" },
            { year: "Root Cause", text: "Models were overfit: trained and 'validated' on same data with errors. 'Perfect' discrimination was data artifacts, not real signal. No independent validation.", type: "revelation" },
            { year: "Lesson", text: "High apparent performance is a RED FLAG without external validation. Development data can memorize noise. Overfitting looks like success ‚Äî until real-world deployment.", type: "revelation" }
          ],
          realData: {
            endpoint: "Chemotherapy response",
            claimed: "C-statistic ~0.90-1.0",
            actual: "Rumore ed errori di dati",
            harm: "Patients enrolled in trials based on fabricated models"
          },
          hook: "THE HOOK: The Duke researchers had 'perfect' predictions. C-statistics near 1.0. Publications in top journals. Clinical trials. The only problem? The models were completely wrong. Overfitting and data errors masqueraded as breakthrough science. This is why validation isn't optional ‚Äî it's the only thing that matters."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è KEY INSIGHT: Development performance is meaningless. A model can achieve C = 0.99 on development data by memorizing noise. Only EXTERNAL validation ‚Äî testing on completely new data ‚Äî reveals true performance. If someone shows you only development metrics, you know nothing about whether the model works."
        }
      },
      {
        type: 'content',
        content: {
          title: "Il PICOT dei modelli prognostici",
          sections: [
            {
              heading: "P ‚Äî Population:",
              text: "Per chi √® questo modello? Definire i criteri di inclusione/esclusione. Il modello si applica SOLO a pazienti simili. Un modello per i pazienti in terapia intensiva non si applica ai pazienti ambulatoriali."
            },
            {
              heading: "I ‚Äî Index (Predictors):",
              text: "Quali informazioni vengono inserite nel modello? Dati demografici, laboratori, imaging, genomica? Tutti i predittori devono essere disponibili al momento della previsione."
            },
            {
              heading: "C ‚Äî Comparator (Alternative Models):",
              text: "What are we comparing to? Existing models? Clinical judgment? No model? New models should IMPROVE on existing options."
            },
            {
              heading: "O ‚Äî Outcome:",
              text: "Cosa stiamo prevedendo? Morte? Riammissione? Progressione della malattia? Deve essere clinicamente significativo, oggettivamente misurabile e importante per i pazienti/medici."
            },
            {
              heading: "T ‚Äî Time Horizon:",
              text: "QUANDO stiamo prevedendo? Mortalit√† a 30 giorni? Sopravvivenza a 5 anni? Rischio a 10 anni? L'orizzonte temporale cambia tutto: predittori, prestazioni e utilit√† clinica."
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: FASI DI SVILUPPO DEL MODELLO",
          title: "Building a Prognostic Model",
          sections: [
            {
              heading: "1. Assemble the Cohort:",
              text: "‚Ä¢ Coorte iniziale con punto di partenza chiaro ‚Ä¢ Dimensioni adeguate del campione (‚â•10 eventi per predittore, preferibilmente ‚â•20) ‚Ä¢ Follow-up completo attraverso l'orizzonte temporale ‚Ä¢ Rappresentativo della popolazione target"
            },
            {
              heading: "2. Select Predictors:",
              text: "‚Ä¢ Basato su prove precedenti, non selezione basata sui dati ‚Ä¢ Disponibile al momento della previsione (nessuna informazione futura) ‚Ä¢ Misurato in modo affidabile e coerente ‚Ä¢ Gestire i dati mancanti PRIMA modellazione"
            },
            {
              heading: "3. Choose the Model Type:",
              text: "‚Ä¢ Logistic regression: Binary outcomes at fixed time\n‚Ä¢ Cox regression: Time-to-event data\n‚Ä¢ Machine learning: Flexible but prone to overfitting\n‚Ä¢ Simpler models often generalize better"
            },
            {
              heading: "4. Fit the Model:",
              text: "‚Ä¢ Pre-specificare la strategia di modellazione ‚Ä¢ Utilizzare penalizzazione (LASSO, cresta) se molti predittori ‚Ä¢ Controllare le ipotesi (linearit√†, rischi proporzionali) ‚Ä¢ Validazione interna con bootstrap o convalida incrociata"
            },
            {
              heading: "5. Apply Shrinkage:",
              text: "‚Ä¢ I coefficienti stimati sono ottimistici (overfit) ‚Ä¢ Calcolare il fattore di contrazione (uniforme o penalizzato) ‚Ä¢ Applicare a tutti i coefficienti prima modello 'finale' ‚Ä¢ Ci√≤ riduce l'overfitting"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Sample Size: The Events Per Variable Rule",
          sections: [
            {
              heading: "The Problem:",
              text: "Con troppo pochi eventi di risultato rispetto ai predittori, i modelli si overfittano in modo catastrofico. Si adattano al rumore, non al segnale."
            },
            {
              heading: "Traditional Rule: EPV ‚â• 10",
              items: [
                "At least 10 events per predictor variable",
                "Per 10 predittori, sono necessari ‚â•100 eventi",
                "Minimum for stable coefficient estimates",
                "Many experts now recommend EPV ‚â• 20"
              ]
            },
            {
              heading: "Example Calculation:",
              text: "You want to develop a model with 12 predictors for 30-day mortality. Mortality rate is 5%. For EPV=10: need 120 events. At 5% rate: need 120/0.05 = 2,400 patients. For EPV=20: need 4,800 patients."
            },
            {
              heading: "When EPV Is Low:",
              items: [
                "Use penalization (LASSO, ridge regression)",
                "Reduce number of predictors (combine, eliminate)",
                "Consider simpler models",
                "Be very skeptical of apparent performance"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "DIVE DEEP: METODI DI PENALIZZAZIONE",
          title: "LASSO, Ridge, and Elastic Net Explained",
          sections: [
            {
              heading: "The Problem Penalization Solves:",
              text: "La regressione standard trova i coefficienti che si adattano MEGLIO ai dati di addestramento. Ma \"miglior adattamento\" spesso significa \"rumore eccessivo\". La penalizzazione aggiunge un COST per coefficienti grandi, costringendo il modello a trovare soluzioni pi√π semplici."
            },
            {
              heading: "Ridge Regression (L2 Penalty):",
              text: "‚Ä¢ Adds penalty = Œª √ó Œ£(Œ≤¬≤) ‚Äî sum of squared coefficients\n‚Ä¢ SHRINKS all coefficients toward zero (but never exactly zero)\n‚Ä¢ Good when many predictors contribute small effects\n‚Ä¢ Handles correlated predictors well\n‚Ä¢ Œª controls shrinkage strength: higher Œª = more shrinkage"
            },
            {
              heading: "LASSO (L1 Penalty):",
              text: "‚Ä¢ Adds penalty = Œª √ó Œ£|Œ≤| ‚Äî sum of absolute coefficients\n‚Ä¢ SHRINKS coefficients AND sets some exactly to zero\n‚Ä¢ Performs variable SELECTION (sparse models)\n‚Ä¢ Better when few predictors are truly important\n‚Ä¢ Can be unstable with correlated predictors"
            },
            {
              heading: "Elastic Net (L1 + L2):",
              text: "‚Ä¢ Combina entrambe le penalit√†: Œª‚ÇÅŒ£|Œ≤| + Œª‚ÇÇŒ£(Œ≤¬≤) ‚Ä¢ Ottiene i vantaggi di entrambi: selezione E contrazione raggruppata ‚Ä¢ Spesso la migliore scelta predefinita ‚Ä¢ Due parametri di ottimizzazione (utilizzare la convalida incrociata)"
            },
            {
              heading: "Choosing Lambda (Œª):",
              text: "‚Ä¢ Use cross-validation to find optimal Œª\n‚Ä¢ Œª.min: minimizes prediction error\n‚Ä¢ Œª.1se: largest Œª within 1 SE of minimum (more parsimonious)\n‚Ä¢ Clinical prediction often uses Œª.1se for simplicity"
            },
            {
              heading: "Critical Limitation:",
              text: "Penalization REDUCES overfitting but doesn't ELIMINATE it. With EPV < 5, even LASSO cannot rescue a model. Penalization is not a substitute for adequate sample size ‚Äî it's a tool for when you have borderline-adequate data."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'penalization-choice',
          title: "Quale metodo di penalizzazione?",
          situation: "Hai 200 eventi e 30 predittori candidati (EPV ‚âà 7). Sospetti che solo 5-8 predittori contino davvero, ma non sei sicuro di quali. Alcuni predittori sono correlati (ad esempio, pressione sistolica e diastolica).",
          nodes: {
            start: {
              question: "Dato che si sospetta che pochi predittori siano importanti ma hanno variabili correlate, quale metodo?",
              branches: [
                { text: "LASSO ‚Äî I want variable selection", nextNode: "lasso_choice" },
                { text: "Ridge ‚Äî handles correlated predictors better", nextNode: "ridge_choice" },
                { text: "Elastic Net ‚Äî gets benefits of both", nextNode: "elastic_correct" }
              ]
            },
            lasso_choice: {
              type: 'outcome',
              outcome: 'partial',
              title: "LASSO has a weakness here",
              text: "LASSO esegue la selezione desiderata. Ma con i predittori correlati (variabili BP), LASSO sceglie arbitrariamente UNO e azzera l'altro. Questo pu√≤ essere instabile: piccole modifiche ai dati cambiano la variabile da mantenere. La rete elastica lo gestisce meglio.",
              lesson: "LASSO √® ottimo per la selezione sparsa ma ha difficolt√† con i predittori correlati. Considera la rete elastica quando i predittori sono correlati."
            },
            ridge_choice: {
              type: 'outcome',
              outcome: 'partial',
              title: "Ridge won't give you selection",
              text: "Ridge gestisce bene i predittori correlati ed √® molto stabile. Ma mantiene TUTTI i 30 predittori (li riduce semplicemente). Se ritieni che solo 5-8 contino, avrai un modello inutilmente complesso. Per l'uso clinico, pi√π semplice √® spesso migliore.",
              lesson: "Ridge √® stabile ma non semplifica. Quando si desidera un modello parsimonioso, √® necessario L1 (LASSO) o rete elastica."
            },
            elastic_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "La scelta migliore per questo scenario!",
              text: "La rete elastica combina la selezione di LASSO con la stabilit√† della cresta per i predittori correlati. Probabilmente selezioner√† 5-10 predittori gestendo con garbo la correlazione BP. Utilizzare la convalida incrociata per ottimizzare sia Œª‚ÇÅ che Œª‚ÇÇ (o il parametro di miscelazione Œ±).",
              lesson: "In caso di dubbio, la rete elastica √® spesso la scelta pi√π sicura: si adatta sia a strutture di segnale sparse che dense."
            }
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'sample-size-decision',
          title: "Questo modello √® adeguatamente alimentato?",
          situation: "Un documento presenta un nuovo modello di previsione della mortalit√† per i pazienti affetti da COVID-19. Hanno 500 pazienti con 75 decessi (mortalit√† del 15%). Hanno testato 25 candidati predittori e ne hanno selezionati 8 per il modello finale. La convalida interna tramite bootstrap mostra la statistica C di 0,82.",
          nodes: {
            start: {
              question: "Qual √® la tua prima preoccupazione?",
              branches: [
                { text: "EPV is low: 75 events / 8 predictors = 9.4", nextNode: "epv_correct" },
                { text: "La statistica C 0,82 non √® cos√¨ impressionante", nextNode: "cstat_issue" },
                { text: "They tested 25 predictors but only used 8", nextNode: "selection_correct" }
              ]
            },
            epv_correct: {
              situation: "Correct ‚Äî EPV is below 10. But there's an even bigger problem...",
              question: "Gli autori hanno testato 25 candidati predittori prima di selezionarne 8. Perch√© questo problematico?",
              branches: [
                { text: "They wasted statistical power on non-significant predictors", nextNode: "power_wrong" },
                { text: "The effective EPV is 75/25 = 3, not 75/8", nextNode: "effective_epv_correct" }
              ]
            },
            cstat_issue: {
              type: 'outcome',
              outcome: 'partial',
              title: "La statistica C va bene, ma non √® questo il problema",
              text: "C = 0.82 would be good if it holds in external validation. The problem is that with low EPV and data-driven selection, this C-statistic is almost certainly OPTIMISTIC. The true external performance is probably much lower.",
              lesson: "Giudicare lo sviluppo del modello in base alla dimensione del campione e ai metodi, non in base ai parametri di prestazione riportati."
            },
            power_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Non si tratta di \"spreco di potere\"",
              text: "Il problema non √® il potere, ma l'ECCESSO DI ADESIONE. Quando provi 25 predittori su 75 eventi, alcuni appariranno predittivi PER CASO. La selezione di predittori \"significativi\" sfrutta questi risultati casuali. Il modello √® costruito in parte sul rumore.",
              lesson: "Data-driven predictor selection (testing many, keeping 'significant' ones) is a major source of overfitting."
            },
            selection_correct: {
              situation: "Good catch! They tested 25 predictors with only 75 events. The effective EPV is 75/25 = 3.",
              question: "What should they have done instead?",
              branches: [
                { text: "Pre-specify 5-6 predictors based on prior evidence", nextNode: "prespecify_correct" },
                { text: "Use LASSO to select predictors automatically", nextNode: "lasso_partial" },
                { text: "Collect more data before testing any predictors", nextNode: "more_data_partial" }
              ]
            },
            effective_epv_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Exactly right!",
              text: "The effective degrees of freedom used is ALL 25 predictors that were tested, not just the 8 that were kept. EPV = 75/25 = 3, which is catastrophically low. The model is almost certainly overfit, regardless of what the bootstrap validation shows.",
              lesson: "L'EPV dovrebbe essere calcolato sulla base di TUTTI i predittori testati, non solo di quelli del modello finale. La selezione basata sui dati non \"salva\" i gradi di libert√†."
            },
            prespecify_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Best practice!",
              text: "Pre-specifying a small number of predictors based on prior clinical knowledge (not this dataset) would give EPV = 75/6 ‚âà 12.5. Combined with shrinkage, this might produce a generalizable model. Data-driven selection should be avoided when EPV is limited.",
              lesson: "La pre-specificazione basata sulla conoscenza clinica, non la selezione basata sui dati, √® il fondamento di un solido sviluppo del modello."
            },
            lasso_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "LASSO helps, but doesn't fully solve the problem",
              text: "LASSO √® migliore della selezione graduale perch√© applica la penalizzazione. Ma con 75 eventi e 25 candidati, anche LASSO probabilmente manterr√† alcune variabili di rumore. √à ancora necessaria una dimensione del campione adeguata.",
              lesson: "Penalization reduces overfitting but doesn't eliminate it. When EPV is very low, no statistical technique can compensate."
            },
            more_data_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Ideal but not always possible",
              text: "More data is always better. But in an emerging pandemic, you may need to build models with what's available. The solution: use prior knowledge to select a small number of predictors, accept that initial models are preliminary, and plan for validation and updating.",
              lesson: "When data is limited, simplicity is essential. Complex models require large datasets."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A model shows C-statistic of 0.90 in development but 0.65 in external validation. The most likely explanation is:",
          options: [
            { id: 'a', text: "La popolazione di validazione esterna era diversa (case-mix)", correct: false },
            { id: 'b', text: "Sovraadattamento nel gruppo di sviluppo", correct: true },
            { id: 'c', text: "Errore di misurazione nei dati esterni", correct: false },
            { id: 'd', text: "Il modello √® in realt√† ben calibrato", correct: false }
          ],
          explanation: "A drop from 0.90 to 0.65 is dramatic (Œî = 0.25). While case-mix differences can reduce discrimination, this magnitude of drop strongly suggests overfitting. The development C-statistic was inflated by fitting noise. The external validation reveals the true (much lower) performance."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è THE WARNING: The Duke scandal happened because prestigious researchers, top journals, and major institutions all accepted 'perfect' model performance without independent validation. Overfitting doesn't look like failure ‚Äî it looks like remarkable success. High development performance should trigger SKEPTICISM, not celebration."
        }
      }
    ]
  },
  {
    id: 3,
    title: "The Performance",
    subtitle: "Discrimination & Calibration",
    principle: 2,
    estimatedTime: "45 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "La discriminazione non √® sufficiente"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE CALIBRATION CRISIS: FRAMINGHAM IN EUROPE ‚Äî WHEN A GOOD MODEL GAVE BAD NUMBERS",
          source: "Brindle 2003 | Heart | SCORE investigators | European populations",
          timeline: [
            { year: "1998", text: "Framingham Risk Score published. Excellent discrimination (C ~0.77). Becomes global standard for CVD risk assessment.", type: "normal" },
            { year: "2000s", text: "European countries adopt Framingham. Cardiologists calculate 10-year risks. Treatment decisions based on thresholds (e.g., >20% = high risk).", type: "normal" },
            { year: "2003", text: "Brindle et al. validate Framingham in UK population. DISCRIMINATION preserved (C similar). But CALIBRATION failed: Framingham predicted 47% more events than observed.", type: "crisis" },
            { year: "The Problem", text: "Framingham developed in US (higher CVD rates). Applied to UK (lower rates). The MODEL ranked patients correctly (discrimination) but gave WRONG PROBABILITIES (calibration).", type: "crisis" },
            { year: "Consequence", text: "Patients told '25% risk' when true risk was ~17%. Millions prescribed statins based on inflated numbers. Cost, side effects, psychological harm.", type: "crisis" },
            { year: "Solution", text: "SCORE, QRISK sviluppato per le popolazioni europee. Ricalibrazione ai tassi di incidenza locale. Il modello deve adattarsi alla popolazione.", type: "revelation" }
          ],
          realData: {
            endpoint: "10-year CVD events",
            discrimination: "C-statistic similar (0.75-0.77)",
            calibration: "Predicted 47% more events than observed",
            ratio: "Predicted/Observed = 1.47"
          },
          hook: "THE HOOK: Framingham DISCRIMINATED perfectly in Europe ‚Äî it correctly ranked who was higher vs lower risk. But it gave WRONG NUMBERS. A patient with 10% true risk was told 15%. This is the calibration problem: discrimination tells you WHO is at higher risk; calibration tells you WHAT that risk actually is."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è APPROFONDIMENTI CHIAVE: un modello ha due lavori. DISCRIMINAZIONE: separare i pazienti ad alto rischio da quelli a basso rischio (classifica). CALIBRAZIONE: fornire stime di probabilit√† accurate (numeri). Un modello pu√≤ asso l'uno e fallire l'altro. Entrambi sono necessari per le decisioni cliniche."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "REAL-WORLD CASE: THE FRAMINGHAM RISK SCORE DECAY ‚Äî WHEN TIME ERODES ACCURACY",
          source: "Framingham Heart Study | Ridker 2016 | Population-level temporal drift",
          timeline: [
            { year: "1998", text: "Il Framingham Risk Score √® pubblicato con eccellente precisione per prevedere le malattie cardiache nelle popolazioni americane contemporanee. Statistica C circa 0,76-0,79.", type: "normal" },
            { year: "2000s", text: "Il punteggio diventa il gold standard. Milioni di prescrizioni di statine sono guidate dalle previsioni di Framingham. Le linee guida cliniche ne sanciscono le soglie.", type: "normal" },
            { year: "2010s", text: "Researchers notice systematic overestimation. The model predicts more heart attacks than actually occur. Something has changed.", type: "crisis" },
            { year: "The Cause", text: "La POPOLAZIONE si √® evoluta mentre il MODELLO √® rimasto congelato. L‚Äôuso delle statine si √® diffuso. I tassi di fumo sono crollati. Il controllo della pressione arteriosa √® migliorato. Il rischio di base √® diminuito.", type: "revelation" },
            { year: "2016", text: "Studies confirm Framingham systematically overestimates risk in modern populations. A model calibrated to 1998 Americans no longer fits 2016 Americans.", type: "crisis" },
            { year: "Lesson", text: "Prediction models are not timeless. As treatments improve, behaviors change, and populations evolve, even excellent models drift out of calibration. Regular recalibration is essential. <span class='lesson-gold'>THE LESSON: Models need maintenance. A prediction frozen in time will eventually mislead as the world around it changes.</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "10-year cardiovascular disease risk",
            model: "Framingham Risk Score (1998 coefficients)",
            problem: "Systematic overestimation by 2010s",
            cause: "Population-level changes in baseline risk factors"
          },
          hook: "THE HOOK: The Framingham Risk Score didn't suddenly become a bad model. It was always a snapshot of 1998 America. But populations don't stand still. When statins, smoking cessation, and better blood pressure control changed baseline risk, the model's predictions drifted from reality. This is TEMPORAL CALIBRATION DRIFT ‚Äî and it affects every long-lived prediction model."
        }
      },
      {
        type: 'content',
        content: {
          title: "Discriminazione: statistica C (AUC)",
          sections: [
            {
              heading: "What It Measures:",
              text: "La probabilit√† che un paziente selezionato casualmente CON l'esito abbia un rischio previsto pi√π elevato rispetto a un paziente selezionato casualmente SENZA l'esito."
            },
            {
              heading: "Interpretation:",
              items: [
                "C = 0.50: No discrimination (coin flip)",
                "C = 0.60-0.70: Poor to modest discrimination",
                "C = 0.70-0.80: Acceptable discrimination",
                "C = 0.80-0.90: Excellent discrimination",
                "C > 0.90: Outstanding (or suspicious ‚Äî check for overfitting)"
              ]
            },
            {
              heading: "Limitations:",
              items: [
                "Non indica se i rischi previsti sono CORRETTO",
                "Can be high even with terrible calibration",
                "Hard to improve in well-developed clinical areas",
                "Depends on case-mix (heterogeneity of population)"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Calibrazione: i numeri sono giusti?",
          sections: [
            {
              heading: "What It Measures:",
              text: "Agreement between predicted probabilities and observed event rates. Among patients predicted 20% risk, do 20% actually have events?"
            },
            {
              heading: "Calibration-in-the-Large:",
              text: "Overall: Does the model predict the right NUMBER of events? If 100 events are predicted but 60 occur, the model overestimates (P/O = 1.67)."
            },
            {
              heading: "Calibration Slope:",
              items: [
                "Regress observed outcomes on predicted probabilities",
                "Ideal slope = 1.0 (perfect agreement)",
                "Slope < 1.0: Predictions too extreme (overfitting)",
                "Slope > 1.0: Predictions too conservative"
              ]
            },
            {
              heading: "Calibration Plot:",
              items: [
                "X-axis: Predicted probability (deciles or smooth)",
                "Y-axis: Observed event rate",
                "Perfect calibration: Points on 45-degree line",
                "Il grafico ESSENZIALE per la validazione del modello"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: LETTURA DI UN TRACCIATO DI CALIBRAZIONE",
          title: "Patterns and What They Mean",
          sections: [
            {
              heading: "Perfect Calibration:",
              text: "Tutti i punti sulla diagonale. Previsto 10% ‚Üí osservato 10%. 50% previsto ‚Üí 50% osservato. Questo √® l'obiettivo."
            },
            {
              heading: "Overestimation (Above Diagonal):",
              text: "Predicted risks too HIGH. Model says 30% but observed is 20%. Framingham in Europe. Leads to overtreatment."
            },
            {
              heading: "Underestimation (Below Diagonal):",
              text: "Predicted risks too LOW. Model says 10% but observed is 15%. Leads to undertreatment. Patients falsely reassured."
            },
            {
              heading: "Poor Calibration Slope:",
              text: "Predictions too SPREAD OUT (slope < 1) or too NARROW (slope > 1). Low-risk too low, high-risk too high = overfitting."
            },
            {
              heading: "Recalibration:",
              text: "If discrimination is good but calibration poor, RECALIBRATE: update intercept (baseline risk) and/or slope (coefficient shrinkage) to fit local population."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'discrimination-calibration',
          title: "Discrimination vs Calibration",
          situation: "You're evaluating two ICU mortality models for your hospital.\n\nModel A: C-statistic 0.85, but predicts 40% mortality when your observed rate is 25%.\nModel B: C-statistic 0.72, but calibration is excellent (predicted/observed = 1.02).",
          nodes: {
            start: {
              question: "Quale modello dovresti utilizzare per la comunicazione con i pazienti (raccontare ai pazienti il ‚Äã‚Äãloro rischio)?",
              branches: [
                { text: "Model A ‚Äî better discrimination", nextNode: "model_a_comm" },
                { text: "Model B ‚Äî better calibration", nextNode: "model_b_comm_correct" }
              ]
            },
            model_a_comm: {
              type: 'outcome',
              outcome: 'danger',
              title: "Patients would get wrong numbers!",
              text: "Il modello A direbbe ai pazienti che il loro rischio √® del 40% quando in realt√† √® del 25%. Ci√≤ causa inutili sofferenze, influenza le decisioni sui trattamenti aggressivi e fuorvia le famiglie. Per la comunicazione, la CALIBRAZIONE √® essenziale: sono necessari i numeri corretti.",
              lesson: "Patient communication requires calibrated probabilities. Telling someone '40% chance of death' when it's really 25% is harmful misinformation."
            },
            model_b_comm_correct: {
              situation: "Correct! For telling patients their risk, calibration matters most.",
              question: "Now: which model should you use to TRIAGE patients (decide who gets ICU vs step-down)?",
              branches: [
                { text: "Model A ‚Äî better discrimination for ranking patients", nextNode: "model_a_triage_correct" },
                { text: "Model B ‚Äî still need correct numbers", nextNode: "model_b_triage" }
              ]
            },
            model_a_triage_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct ‚Äî for ranking, discrimination matters!",
              text: "Triage is about ranking: who is higher risk? Model A (C=0.85) better separates sick from less-sick patients. You don't need the exact probability to rank. Model A's miscalibration doesn't affect who gets ranked higher vs lower.",
              lesson: "L'attivit√† determina la metrica: la CLASSIFICA richiede discriminazione. La PROBABILIT√Ä necessita di calibrazione. Abbina la metrica alla domanda clinica."
            },
            model_b_triage: {
              type: 'outcome',
              outcome: 'partial',
              title: "Calibration is less critical for ranking",
              text: "For triage, you're RANKING patients, not quoting probabilities. Model A separates high-risk from low-risk better (C=0.85 vs 0.72). Even though Model A's numbers are off, its RANKINGS are better. Use A for triage, B for communication.",
              lesson: "Attivit√† cliniche diverse richiedono propriet√† del modello diverse. Molti modelli vengono utilizzati per molteplici scopi: comprendi cosa richiede ciascun utilizzo."
            }
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'calibration-plot-reading',
          title: "Reading Calibration Plots",
          situation: "Stai esaminando uno studio di convalida. Il grafico di calibrazione mostra: ‚Ä¢ Decile 1 (previsto 5%): osservato 8% ‚Ä¢ Decile 5 (previsto 25%): osservato 24% ‚Ä¢ Decile 10 (previsto 60%): osservato 45% I punti formano una curva che inizia SOTTO la diagonale in caso di rischio basso e attraversa SOPRA la diagonale in caso di rischio elevato.",
          nodes: {
            start: {
              question: "What pattern does this calibration plot show?",
              branches: [
                { text: "Overestimation ‚Äî predictions too high overall", nextNode: "over_wrong" },
                { text: "Poor slope ‚Äî predictions too extreme", nextNode: "slope_correct" },
                { text: "Good calibration ‚Äî points are close to diagonal", nextNode: "good_wrong" }
              ]
            },
            over_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Look at the pattern more carefully",
              text: "At LOW predicted risk (5%), observed was HIGHER (8%) ‚Äî that's underestimation. At HIGH predicted risk (60%), observed was LOWER (45%) ‚Äî that's overestimation. The model isn't consistently over- or under-estimating; it's making predictions that are too EXTREME.",
              lesson: "I problemi di calibrazione si presentano in diversi modelli. La sovra/sottostima uniforme differisce dai problemi di pendenza."
            },
            slope_correct: {
              situation: "Correct! Low predictions too low, high predictions too high = slope < 1 (overfitting). Now:",
              question: "La pendenza di calibrazione viene calcolata come 0,65. Come dovrebbe essere ricalibrato il modello?",
              branches: [
                { text: "Multiply all predicted probabilities by 0.65", nextNode: "multiply_wrong" },
                { text: "Ridurre le previsioni verso la media (ristimare con aggiustamento della pendenza)", nextNode: "shrink_correct" }
              ]
            },
            good_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Queste deviazioni sono clinicamente significative!",
              text: "Al 5% del previsto, quello osservato √® dell'8%: ovvero il 60% in pi√π del previsto. Al 60% previsto, quello osservato √® del 45%, ovvero il 25% in meno. Per le decisioni cliniche, dire a un paziente \"rischio di mortalit√† del 60%\" quando in realt√† √® del 45% provoca un danno sostanziale. Queste non sono piccole deviazioni.",
              lesson: "Le deviazioni di calibrazione che sembrano \"piccole\" in termini assoluti possono essere grandi in termini relativi e clinicamente importanti."
            },
            multiply_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "That would make things worse!",
              text: "Moltiplicando tutte le previsioni per 0,65 si abbasserebbero TUTTE le previsioni. Ma le previsioni basse sono gi√† troppo BASSE. √à necessario ridurre le previsioni VERSO LA MEDIA: abbassare quelle alte, aumentare quelle basse. Ci√≤ richiede una nuova stima con il vincolo di pendenza.",
              lesson: "Ricalibrazione per pendenza ‚â† moltiplicazione semplice. Ti riduci verso la media, non verso lo zero."
            },
            shrink_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct recalibration approach!",
              text: "With slope 0.65, you need to shrink predictions toward the mean outcome rate. Mathematically: calibrated_logit = intercept + 0.65 √ó (original_logit). This pulls extreme predictions toward the center. Low-risk predictions increase; high-risk predictions decrease.",
              lesson: "La ricalibrazione della pendenza riduce le previsioni verso la media. Ci√≤ corregge il modello di overfitting in cui il modello era troppo fiducioso in entrambi gli estremi."
            }
          }
        }
      },
      {
        type: 'content',
        content: {
          title: "Communicating Uncertainty to Patients",
          sections: [
            {
              heading: "Why This Matters:",
              text: "Prognostic models ultimately serve patients. A perfectly calibrated model is useless if clinicians can't communicate its outputs clearly. Miscommunication causes as much harm as miscalibration."
            },
            {
              heading: "Phrases That Help:",
              items: [
                "\"Based on patients similar to you...\" (acknowledges model basis)",
                "\"This estimate has uncertainty ‚Äî it could be somewhat higher or lower\" (conveys CI)",
                "\\\"Questa √® una probabilit√†, non una certezza: alcuni pazienti superano le probabilit√†\\\" (evita il determinismo)",
                "\\\"Questo ci aiuta a decidere insieme, non a prevedere esattamente il tuo futuro\\\" (condiviso processo decisionale)",
                "\\\"Se 100 pazienti come te fossero seguiti...\\\" (inquadramento della frequenza)"
              ]
            },
            {
              heading: "Phrases to Avoid:",
              items: [
                "\"You have a 73% chance of...\" (false precision)",
                "\"The computer says...\" (abdicates responsibility)",
                "\\\"Sopravviverai/non sopravvivrai\\\" (linguaggio deterministico)",
                "\\\"Non preoccuparti dei numeri\\\" (sprezzante)",
                "\"This is just a rough estimate\" (undermines useful information)"
              ]
            },
            {
              heading: "Handling Uncertainty:",
              text: "When the model says 30% (95% CI: 20-45%), you might say: 'Based on similar patients, the risk is probably between 1 in 5 and 1 in 2, with our best estimate around 1 in 3. This helps us think about whether aggressive treatment is right for you.'"
            },
            {
              heading: "When Models Conflict with Gestalt:",
              text: "If clinical intuition strongly disagrees with the model, acknowledge it: 'The calculator suggests X, but based on factors it doesn't capture, I think Y is more likely. Let's discuss both perspectives.'"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Competing Risks: The Hidden Complexity",
          sections: [
            {
              heading: "The Problem:",
              text: "L'analisi standard della sopravvivenza presuppone che i pazienti abbiano l'evento o siano censurati (persi al follow-up). Ma cosa succede se Muoiono prima che l‚Äôevento possa verificarsi? La morte \"compete\" con il risultato di interesse."
            },
            {
              heading: "Example:",
              text: "You're predicting hip fracture in elderly patients. A patient dies of heart disease at month 6. They didn't have a hip fracture ‚Äî but they also can't have one in the future. Standard Kaplan-Meier treats them as censored, which OVERESTIMATES fracture risk in survivors."
            },
            {
              heading: "When It Matters:",
              items: [
                "Elderly populations (high competing mortality)",
                "Cancer patients (death competes with recurrence)",
                "Long time horizons (more time for competing events)",
                "Non-fatal outcomes in sick populations"
              ]
            },
            {
              heading: "Solutions:",
              items: [
                "Cause-specific hazards: Model each event separately (traditional)",
                "Subdistribution hazards (Fine-Gray): Accounts for competing risks directly",
                "Multi-state models: Explicitly model transitions between states",
                "Report cumulative incidence, not 1-KM (acknowledges competing risks)"
              ]
            },
            {
              heading: "For Reviewers:",
              text: "When reading prognostic studies in elderly/sick populations with non-fatal outcomes, ask: 'How did they handle competing risks?' If the answer is 'standard Cox/KM,' the predictions may be biased upward."
            }
          ]
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Un modello ha una statistica C di 0,75 e una pendenza di calibrazione di 0,6. Cosa suggerisce questo modello?",
          options: [
            { id: 'a', text: "Good discrimination but predictions are too extreme (overfitting)", correct: true },
            { id: 'b', text: "Poor discrimination and poor calibration overall", correct: false },
            { id: 'c', text: "Il modello sottovaluta il rischio per tutti", correct: false },
            { id: 'd', text: "The model needs more predictors", correct: false }
          ],
          explanation: "C = 0.75 indicates acceptable discrimination. Calibration slope of 0.6 (< 1.0) means predictions are too spread out: high-risk predictions are too high, low-risk predictions are too low. This is the classic pattern of overfitting ‚Äî the model fits noise in development data, producing extreme predictions that don't generalize."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You now understand model performance dimensions AND how to communicate them. Discrimination (C-statistic) = ranking ability. Calibration = probability accuracy. Patient communication requires translating numbers into meaningful, honest conversations. Competing risks matter in elderly/sick populations with non-fatal outcomes."
        }
      }
    ]
  }
,
  {
    id: 4,
    title: "The Validation",
    subtitle: "Internal & External Testing",
    principle: 3,
    estimatedTime: "40 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Pi√π predittori non sono migliori"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE EPIC FAILURE: SEPSIS AI ‚Äî WHEN SILICON VALLEY MET REALITY",
          source: "Wong et al. JAMA Intern Med 2021 | Epic Sepsis Model | External validation",
          timeline: [
            { year: "2017", text: "Epic Systems develops machine learning model for sepsis prediction. Deployed in hundreds of hospitals. Marketing claims strong performance.", type: "normal" },
            { year: "2019", text: "Epic model in widespread clinical use. Alerts firing. Clinicians responding. Assumed to be saving lives.", type: "normal" },
            { year: "2021", text: "Wong et al. publish external validation at Michigan Medicine. C-statistic: 0.63 (poor). PPV at common threshold: 12%. Only 7% of sepsis cases detected.", type: "crisis" },
            { year: "The Gap", text: "Epic's internal 'validation' C = 0.76-0.83. Independent external: C = 0.63. The model performed FAR WORSE in real-world deployment than internal testing suggested.", type: "crisis" },
            { year: "Root Cause", text: "La convalida interna ha utilizzato le STESSE origini dati e popolazioni simili. Nessuna vera convalida esterna prima della distribuzione. Algoritmo distribuito in base alle dichiarazioni dei fornitori.", type: "revelation" },
            { year: "Lesson", text: "L'apprendimento automatico non √® magico. Gli algoritmi proprietari necessitano di una convalida esterna INDIPENDENTE prima dell'implementazione clinica. Le metriche dei fornitori non sono prove.", type: "revelation" }
          ],
          realData: {
            endpoint: "Sepsis onset within 6 hours",
            internal: "C-statistic 0.76-0.83 (Epic's claim)",
            external: "C-statistic 0.63 (independent validation)",
            ppv: "12% at alert threshold"
          },
          hook: "THE HOOK: A proprietary algorithm was deployed in hundreds of hospitals based on vendor-provided metrics. Independent validation revealed it barely worked. Patients received thousands of false alerts while 93% of actual sepsis cases were missed. This is why external validation by INDEPENDENT researchers is essential."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è KEY INSIGHT: Validation has levels. INTERNAL validation (same data) catches obvious overfitting. EXTERNAL validation (new data, new setting) tests generalizability. INDEPENDENT validation (different researchers) catches selective reporting and hidden biases. All three matter."
        }
      },
      {
        type: 'content',
        content: {
          title: "Types of Validation",
          sections: [
            {
              heading: "Internal Validation (Same Data):",
              items: [
                "Bootstrap: Resample with replacement, train and test many times",
                "Cross-validation: Divide data into folds, train on k-1, test on 1, rotate",
                "Split-sample: Train on 70%, test on 30% (weak, wastes data)",
                "Purpose: Estimate optimism from overfitting. MINIMUM requirement."
              ]
            },
            {
              heading: "External Validation (New Data):",
              items: [
                "TEMPORAL: Different time period, same setting",
                "GEOGRAPHIC: Different location, same time period",
                "DOMAIN: Different patient population or clinical context",
                "Purpose: Test generalizability. Required before clinical use."
              ]
            },
            {
              heading: "Independent Validation:",
              items: [
                "Different research team conducts the validation",
                "Eliminates selective reporting, hidden specification searches",
                "L'UNICA validazione che mette veramente alla prova le prestazioni nel mondo reale",
                "Should be required for any high-stakes model deployment"
              ]
            }
          ]
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "REAL-WORLD CASE: THE APACHE SCORE MISADVENTURE ‚Äî WHEN GEOGRAPHY FOOLED EVERYONE",
          source: "APACHE II validation studies | UK Intensive Care Society | Geographic transportability",
          timeline: [
            { year: "1985", text: "APACHE II is developed in US academic medical centers to predict ICU mortality. Based on 5,815 admissions across 13 hospitals. Excellent discrimination.", type: "normal" },
            { year: "Late 1980s", text: "APACHE II becomes the standard for ICU risk adjustment. Hospitals compare their outcomes to APACHE-predicted mortality. 'Better than expected' = quality marker.", type: "normal" },
            { year: "UK Adoption", text: "British hospitals adopt APACHE II for quality benchmarking. The model predicts mortality; actual deaths are compared. Nearly every UK hospital appears to outperform expectations.", type: "crisis" },
            { year: "The Problem", text: "APACHE II √® stata calibrata sulle unit√† di terapia intensiva americane degli anni '80 con una mortalit√† di base pi√π elevata. Le unit√† di terapia intensiva del Regno Unito presentavano un mix di casi diverso, soglie di ammissione anticipate e risultati migliori. Il denominatore del modello era sbagliato.", type: "revelation" },
            { year: "False Reassurance", text: "Hospitals celebrated 'beating' APACHE predictions. But they were being compared to an irrelevant baseline. Poor performers looked adequate; adequate performers looked excellent.", type: "crisis" },
            { year: "Lesson", text: "Geographic external validation isn't just about discrimination ‚Äî it's about CALIBRATION TO LOCAL CONTEXT. A model developed in one healthcare system may systematically mispredict in another. <span class='lesson-gold'>THE LESSON: When a model makes every hospital look good, ask whether the model fits your population ‚Äî or whether you're being fooled by geographic miscalibration.</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "ICU mortality",
            model: "APACHE II (US-developed)",
            problem: "Systematic overestimation in UK",
            consequence: "False reassurance about hospital quality"
          },
          hook: "THE HOOK: APACHE II was a valid model in the wrong context. Its discrimination worked fine ‚Äî it still ranked patients correctly by risk. But its CALIBRATION was anchored to American ICU mortality rates. When UK hospitals used it as a benchmark, they were measuring themselves against the wrong yardstick. Geographic validation without recalibration is a recipe for false confidence."
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: FLUSSO DI LAVORO DI VALIDAZIONE",
          title: "Passi per una convalida rigorosa",
          sections: [
            {
              heading: "1. Obtain Completely Independent Data:",
              text: "‚Ä¢ Tempo, luogo o istituzione diversi ‚Ä¢ Nessuna sovrapposizione con i dati di sviluppo ‚Ä¢ Riflette la popolazione d'uso prevista ‚Ä¢ Eventi sufficienti per stime affidabili (‚â•100 eventi ideale)"
            },
            {
              heading: "2. Apply Model EXACTLY as Developed:",
              text: "‚Ä¢ Stesse definizioni di predittore ‚Ä¢ Stessa gestione delle variabili (dati mancanti, cutoff) ‚Ä¢ Nessun refitting, nessuna modifica ‚Ä¢ Il modello deve funzionare \"out of the box\""
            },
            {
              heading: "3. Assess Discrimination:",
              text: "‚Ä¢ Calculate C-statistic with 95% CI\n‚Ä¢ Compare to development performance\n‚Ä¢ Drop of >0.05 suggests poor generalizability"
            },
            {
              heading: "4. Assess Calibration:",
              text: "‚Ä¢ Calibration plot (essential)\n‚Ä¢ Calibration-in-the-large (P/O ratio)\n‚Ä¢ Calibration slope\n‚Ä¢ Hosmer-Lemeshow test (limited value)"
            },
            {
              heading: "5. Consider Updating If Needed:",
              text: "‚Ä¢ If discrimination OK but calibration poor ‚Üí recalibrate\n‚Ä¢ If discrimination poor ‚Üí model may need redevelopment\n‚Ä¢ Update intercept for new baseline rates\n‚Ä¢ Update slope if predictions too extreme"
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "DEEP DIVE: MODEL UPDATING & RECALIBRATION",
          title: "When and How to Update Existing Models",
          sections: [
            {
              heading: "Why Update Rather Than Rebuild?",
              text: "La creazione di nuovi modelli richiede set di dati di grandi dimensioni e una convalida approfondita. Se un modello esistente discrimina bene ma calibra erroneamente, UPDATING preserva la struttura convalidata mentre corregge la calibrazione. Questo √® spesso pi√π sicuro che iniziare da zero."
            },
            {
              heading: "Level 1: Intercept-Only Recalibration",
              text: "‚Ä¢ Simplest update: adjust baseline risk only\n‚Ä¢ Use when: Model systematically over/under-estimates by a constant factor\n‚Ä¢ Method: Re-estimate intercept using local event rate\n‚Ä¢ Formula: new_intercept = log(local_odds) - mean(linear_predictor)\n‚Ä¢ Preserves all coefficients; only shifts predictions up/down"
            },
            {
              heading: "Level 2: Slope + Intercept Recalibration",
              text: "‚Ä¢ Adjusts both baseline and spread of predictions\n‚Ä¢ Use when: Calibration slope ‚â† 1 (overfitting pattern)\n‚Ä¢ Method: Regress outcomes on linear predictor; use resulting intercept and slope\n‚Ä¢ Shrinks extreme predictions toward mean\n‚Ä¢ Often needed when applying models to new populations"
            },
            {
              heading: "Level 3: Model Revision (Re-estimation)",
              text: "‚Ä¢ Re-estimate some or all coefficients\n‚Ä¢ Use when: Predictor effects differ substantially in new population\n‚Ä¢ Method: Start with original coefficients as priors; update with local data\n‚Ä¢ Bayesian approaches can combine original and new evidence\n‚Ä¢ Requires larger local dataset than simple recalibration"
            },
            {
              heading: "Level 4: Model Extension",
              text: "‚Ä¢ Aggiungere nuovi predittori al modello esistente ‚Ä¢ Utilizzare quando: sono disponibili nuovi biomarcatori o fattori di rischio ‚Ä¢ Metodo: aggiungere nuovi termini preservando la struttura originale ‚Ä¢ √à comunque necessario convalidare il modello esteso esternamente ‚Ä¢ Rischio: i nuovi predittori potrebbero aggiungere rumore anzich√© segnalare"
            },
            {
              heading: "Decision Framework:",
              text: "Discrimination OK + Calibration-in-large off ‚Üí Level 1\nDiscrimination OK + Slope off ‚Üí Level 2\nDiscrimination reduced + Some predictors off ‚Üí Level 3\nNew predictors available ‚Üí Consider Level 4\nDiscrimination poor across predictors ‚Üí Rebuild from scratch"
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'model-updating-decision',
          title: "Dovresti aggiornare o Ricostruire?",
          situation: "Framingham Risk Score is validated at your Asian hospital. Results:\n‚Ä¢ C-statistic: 0.78 (vs 0.79 in original) ‚Äî discrimination preserved\n‚Ä¢ Predicted/Observed events: 1.85 ‚Äî model predicts 85% more events than occur\n‚Ä¢ Calibration slope: 0.95 ‚Äî close to 1.0\n\nThe model systematically overestimates, but rankings are correct.",
          nodes: {
            start: {
              question: "What type of update is most appropriate?",
              branches: [
                { text: "Rebuild a new model for Asian populations", nextNode: "rebuild_wrong" },
                { text: "Level 1: Intercept-only recalibration", nextNode: "level1_correct" },
                { text: "Level 2: Slope + intercept recalibration", nextNode: "level2_partial" }
              ]
            },
            rebuild_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Eccessiva per questo problema!",
              text: "Discrimination is excellent (0.78) ‚Äî the model ranks patients correctly. The slope is 0.95 ‚Äî predictions aren't too extreme. The only problem is SYSTEMATIC overestimation (P/O = 1.85). This is exactly what intercept recalibration fixes. Rebuilding wastes the validated structure.",
              lesson: "Non ricostruire ci√≤ che pu√≤ essere ricalibrato. Se la discriminazione e la pendenza sono buone, la regolazione dell'intercetta √® sufficiente."
            },
            level1_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Perfect choice!",
              text: "C-statistic preserved + slope ~1.0 + systematic over-prediction = Level 1 (intercept-only) recalibration. Simply adjust the baseline risk to reflect lower CVD rates in your Asian population. All the hard work (validated predictors, coefficients) is preserved.",
              lesson: "La ricalibrazione dell'intercettazione √® potente e semplice. √à la prima cosa da provare quando un modello sovra/sottostima sistematicamente."
            },
            level2_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Would work, but more than needed",
              text: "Il livello 2 regola sia l'intercetta che la pendenza. Ma la tua pendenza √® gi√† 0,95 (essenzialmente 1,0): le previsioni non sono troppo estreme, ma solo sistematicamente elevate. Il livello 1 √® pi√π semplice e sufficiente. Utilizzare il livello 2 quando la pendenza devia in modo significativo da 1,0.",
              lesson: "Abbina il livello di aggiornamento al problema. Gli aggiornamenti pi√π semplici sono pi√π robusti e richiedono meno dati."
            }
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'validation-type',
          title: "Che tipo di convalida √® questo?",
          situation: "Classify each validation scenario by type and adequacy.",
          nodes: {
            start: {
              question: "A COVID mortality model developed in Wuhan (2020) is tested on data from Wuhan (2021). This is:",
              branches: [
                { text: "Internal validation ‚Äî same location", nextNode: "internal_wrong" },
                { text: "Temporal external validation", nextNode: "temporal_correct" }
              ]
            },
            internal_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "No ‚Äî different time = external",
              text: "Anche se si tratta dello stesso ospedale, i dati del 2021 sono ESTERNI a una coorte di sviluppo del 2020. Questa √® la convalida esterna TEMPORALE. La popolazione di pazienti, i protocolli di trattamento e le varianti virali possono differire.",
              lesson: "La convalida esterna richiede dati non utilizzati nello sviluppo del modello. La separazione temporale lo rende esterno."
            },
            temporal_correct: {
              situation: "Correct! Different time period = temporal external validation.",
              question: "Lo stesso modello √® ora testato alla Johns Hopkins nel 2021. La statistica C scende da 0,82 a 0,74. Qual √® la tua interpretazione?",
              branches: [
                { text: "The model failed ‚Äî drop is too large", nextNode: "drop_harsh" },
                { text: "Acceptable performance ‚Äî C 0.74 is still adequate", nextNode: "acceptable_correct" },
                { text: "Need to check calibration before judging", nextNode: "calibration_best" }
              ]
            },
            drop_harsh: {
              type: 'outcome',
              outcome: 'partial',
              title: "A drop of 0.08 is concerning but not catastrophic",
              text: "C che scende da 0,82 a 0,74 suggerisce un eccessivo adattamento o differenze nella popolazione. Ma 0,74 fornisce ancora una discriminazione ragionevole. La domanda chiave √®: 0,74 √® clinicamente utile? E per quanto riguarda la calibrazione?",
              lesson: "√à previsto un certo calo della statistica C nella convalida esterna. Giudicate in base alla prestazione assoluta, non solo al calo."
            },
            acceptable_correct: {
              type: 'outcome',
              outcome: 'partial',
              title: "C = 0.74 can be useful, but check calibration",
              text: "Discrimination of 0.74 is often adequate for clinical use. But you don't know if the model works until you check CALIBRATION. A model with C=0.74 but predicted/observed=2.0 would be dangerous.",
              lesson: "Never judge a model by C-statistic alone. Calibration failures can make discriminating models clinically harmful."
            },
            calibration_best: {
              type: 'outcome',
              outcome: 'success',
              title: "Excellent answer!",
              text: "Hai riconosciuto correttamente che la statistica C da sola non √® sufficiente. Un calo da 0,82 a 0,74 √® tollerabile se si mantiene la calibrazione. Se il modello prevede una mortalit√† del 30% ma Johns Hopkins ne vede il 15%, il modello √® DANNOSO nonostante una discriminazione accettabile.",
              lesson: "Always assess BOTH discrimination AND calibration in external validation. Many models discriminate adequately but miscalibrate badly."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A research team develops a model and tests it on a random 30% holdout of their original dataset. This is:",
          options: [
            { id: 'a', text: "Convalida esterna (i dati non sono stati utilizzati per lo sviluppo)", correct: false },
            { id: 'b', text: "Internal validation (same source, doesn't test generalizability)", correct: true },
            { id: 'c', text: "Independent validation (separate test)", correct: false },
            { id: 'd', text: "Nessuna convalida (non √® possibile convalidare i dati di controllo)", correct: false }
          ],
          explanation: "Split-sample validation is a form of INTERNAL validation. The holdout data comes from the same time, place, and population as the development data. It does NOT test generalizability to new settings. This is the weakest form of validation ‚Äî better than nothing, but far from sufficient for clinical deployment."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è L'AVVERTIMENTO: The Epic La debacle della sepsi mostra che i fornitori commercializzeranno modelli basati su parametri interni. Gli ospedali li distribuiranno senza test indipendenti. I pazienti saranno sottoposti ad algoritmi che ‚Äúfunzionano sulla carta‚Äù ma falliscono nella pratica. Richiedi sempre una validazione esterna indipendente."
        }
      }
    ]
  },
  {
    id: 5,
    title: "The Scores",
    subtitle: "Clinical Prediction Rules",
    principle: 4,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "La popolazione definisce la previsione"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "LA STORIA DI SUCCESSO: I CRITERI DI WELLS ‚Äî QUANDO LA SEMPLICIT√Ä HA SALVATO VITE",
          source: "Wells et al. 1998-2006 | Ann Intern Med | Thrombosis",
          timeline: [
            { year: "1995", text: "Philip Wells develops simple scoring system for DVT probability. Clinical signs + risk factors = points. No fancy math, no computers required.", type: "normal" },
            { year: "1997", text: "Wells DVT score validated: Low probability patients have <5% DVT prevalence. Can safely avoid imaging with negative D-dimer.", type: "revelation" },
            { year: "2000", text: "Wells PE score developed for pulmonary embolism. Similar simplicity: 7 items, integer points, three risk categories.", type: "normal" },
            { year: "2006", text: "Punteggio Wells PE ampiamente convalidato. Combinato con i protocolli PERC, D-dimero e CTPA. Milioni di pazienti del pronto soccorso stratificati in base al rischio.", type: "revelation" },
            { year: "Impact", text: "Reduced unnecessary CT scans. Reduced radiation exposure. Faster diagnoses. Lives saved by rapid identification of high-risk patients.", type: "revelation" },
            { year: "Why It Worked", text: "Semplice (memorizzabile), validato (esternamente, ripetutamente), integrato (con percorso diagnostico) e clinicamente utile (modifica le decisioni).", type: "revelation" }
          ],
          realData: {
            endpoint: "DVT/PE presence",
            model: "Wells Score (DVT and PE versions)",
            discrimination: "C-statistic 0.70-0.75",
            impact: "Standard of care in emergency medicine worldwide"
          },
          hook: "THE HOOK: Wells criteria have modest C-statistics (0.70-0.75) ‚Äî not impressive by AI standards. But they're memorizable, interpretable, validated, and integrated into care pathways. They've saved more lives than any black-box algorithm. Sometimes simple wins."
        }
      },
      {
        type: 'content',
        content: {
          title: "Famous Clinical Prediction Rules",
          sections: [
            {
              heading: "Cardiovascular:",
              items: [
                "Framingham/ASCVD: 10-year CVD risk ‚Üí statin decisions",
                "CHA‚ÇÇDS‚ÇÇ-VASc: Stroke risk in AF ‚Üí anticoagulation",
                "HEART Score: Chest pain risk stratification ‚Üí discharge vs admit",
                "TIMI Risk Score: ACS prognosis ‚Üí treatment intensity"
              ]
            },
            {
              heading: "Emergency Medicine:",
              items: [
                "Wells DVT/PE: Thromboembolism probability ‚Üí testing strategy",
                "PERC: Rule out PE without testing",
                "Canadian C-Spine/CT Head: Imaging decisions after trauma",
                "Ottawa Ankle/Knee: X-ray necessity for injuries"
              ]
            },
            {
              heading: "Critical Care:",
              items: [
                "APACHE II/III/IV: ICU mortality prediction",
                "SOFA: Sequential organ failure assessment",
                "qSOFA: Quick sepsis screening (controversial)",
                "CURB-65: Pneumonia mortality ‚Üí admit vs discharge"
              ]
            },
            {
              heading: "What Makes Them Work:",
              items: [
                "Simple enough to use at bedside without calculator",
                "Validated extensively across populations",
                "Integrato nei flussi di lavoro e nelle linee guida cliniche",
                "Clear decision thresholds with actionable implications"
              ]
            }
          ]
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE CONTROVERSY: qSOFA ‚Äî WHEN A SCORE DIVIDED MEDICINE",
          source: "Seymour et al. JAMA 2016 | Singer et al. JAMA 2016 | Sepsis-3",
          timeline: [
            { year: "2016", text: "Sepsis-3 consensus redefines sepsis. Introduces qSOFA: 3 simple criteria (RR‚â•22, SBP‚â§100, altered mental status). 2+ points = 'think sepsis'.", type: "normal" },
            { year: "The Promise", text: "qSOFA is beautifully simple. No lab tests. Bedside assessment. Could identify sepsis risk anywhere, anytime. International uptake rapid.", type: "normal" },
            { year: "External Validation", text: "Gli studi si riversano. Risultati contrastanti. qSOFA ha SPECIFICIT√Ä (se positivo, prognosi infausta) ma scarsa SENSIBILIT√Ä (non tiene conto di molti casi di sepsi). C ~0,65-0,70.", type: "crisis" },
            { year: "The Debate", text: "Is qSOFA for SCREENING (must be sensitive) or PROGNOSIS (can be specific)? Guidelines unclear. Emergency physicians frustrated: patients die with qSOFA=1.", type: "crisis" },
            { year: "Current Status", text: "qSOFA utile per la prognosi (il positivo predice la mortalit√†) ma NON per lo screening (il negativo non esclude la sepsi). Strumenti diversi per scopi diversi.", type: "revelation" },
            { year: "Lesson", text: "A score's PURPOSE determines its required properties. Screening tools need sensitivity. Prognostic tools can trade sensitivity for specificity. Mismatched purpose = clinical failure.", type: "revelation" }
          ],
          realData: {
            endpoint: "ICU mortality, prolonged stay",
            model: "qSOFA (RR‚â•22, SBP‚â§100, AMS)",
            discrimination: "C-statistic 0.65-0.70",
            sensitivity: "45-60% per la diagnosi di sepsi"
          },
          hook: "THE HOOK: qSOFA is a great PROGNOSTIC tool ‚Äî qSOFA‚â•2 means poor prognosis. But it was marketed as a SCREENING tool, where it fails (misses half of sepsis). The lesson: Know your score's purpose. A prognostic score isn't a screening score."
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'score-selection',
          title: "Scegliere il punteggio giusto",
          situation: "You're in the emergency department with a patient presenting with shortness of breath. You suspect PE. Multiple scores exist: Wells PE, Geneva, PERC, YEARS. How do you decide?",
          nodes: {
            start: {
              question: "What should guide your choice of score?",
              branches: [
                { text: "Utilizza il punteggio con la statistica C pi√π alta", nextNode: "cstat_wrong" },
                { text: "Utilizza il punteggio convalidato nella tua popolazione e integrato nella tua flusso di lavoro", nextNode: "workflow_correct" },
                { text: "Use all scores and average them", nextNode: "average_wrong" }
              ]
            },
            cstat_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "C-statistic isn't everything",
              text: "These scores have similar C-statistics (0.70-0.75). The differences are in: what populations they're validated for, how they integrate with testing (D-dimer, CTPA), and whether your institution has pathways built around them. Implementation matters more than small statistical differences.",
              lesson: "Among validated scores, choose based on local validation, workflow integration, and clinical pathway support."
            },
            workflow_correct: {
              situation: "Excellent! Your institution uses Wells + D-dimer protocol. Now: a patient has Wells score of 2 ('PE unlikely'). D-dimer is elevated. What next?",
              question: "Your action:",
              branches: [
                { text: "PE is unlikely based on Wells ‚Äî reassure and discharge", nextNode: "discharge_wrong" },
                { text: "Elevated D-dimer overrides Wells ‚Äî get CTPA", nextNode: "ctpa_correct" }
              ]
            },
            average_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Ci√≤ causerebbe il caos!",
              text: "Scores aren't designed to be averaged. They have different thresholds, different action points, and different integration with testing. PERC rules out without testing; Wells guides D-dimer interpretation. Using multiple scores without understanding their roles leads to inconsistent care.",
              lesson: "Comprendi lo SCOPO e il PERCORSO di ciascun punteggio. Selezionare un punteggio per percorso e utilizzarlo in modo coerente."
            },
            discharge_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Dangerous decision!",
              text: "'PE unlikely' (Wells ‚â§4) means D-dimer can rule out PE. But if D-dimer is ELEVATED in a 'PE unlikely' patient, they need imaging. The pathway is: Wells ‚Üí D-dimer ‚Üí CTPA if D-dimer positive. You can't stop at Wells when D-dimer is abnormal.",
              lesson: "Le regole di previsione clinica fanno solitamente parte dei PATHWAYS, non di decisioni autonome. Segui l'algoritmo completo."
            },
            ctpa_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct clinical pathway!",
              text: "Wells 'PE unlikely' + negative D-dimer = rule out PE. Wells 'PE unlikely' + positive D-dimer = CTPA needed. The score stratifies who needs D-dimer, but the final decision combines score + D-dimer result.",
              lesson: "Le regole di previsione clinica spesso si combinano con i test diagnostici nei percorsi. Il punteggio da solo non prende la decisione."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "CHA‚ÇÇDS‚ÇÇ-VASc has a C-statistic of only 0.60-0.65 for predicting stroke in atrial fibrillation. Despite this modest discrimination, it's useful because:",
          options: [
            { id: 'a', text: "It perfectly calibrated in all populations", correct: false },
            { id: 'b', text: "It identifies a low-risk group (score 0-1) who can avoid anticoagulation", correct: true },
            { id: 'c', text: "√à l'unico punteggio disponibile per questo scopo", correct: false },
            { id: 'd', text: "La statistica C √® misurata in modo errato", correct: false }
          ],
          explanation: "L'utilit√† clinica di CHA‚ÇÇDS‚ÇÇ-VASc non deriva dall'elevata discriminazione in generale, ma dall'identificazione di un gruppo A BASSO RISCHIO. I pazienti con punteggio 0 (o 1 nelle donne) hanno un rischio di ictus sufficientemente basso da rendere non necessaria la terapia anticoagulante. Il valore del punteggio sta nell'escludere, non nel prevedere."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "CASO DEL MONDO REALE: LA STORIA DI SUCCESSO DI ONCOTYPE DX: GUADAGNARE LA FIDUCIA ATTRAVERSO LA CONVALIDA",
          source: "Paik et al. NEJM 2004 | TAILORx Trial 2018 | Breast cancer prognostics",
          timeline: [
            { year: "2004", text: "Oncotype DX is introduced: a 21-gene assay that generates a Recurrence Score (0-100) for early-stage, hormone receptor-positive breast cancer. Claims to predict chemotherapy benefit.", type: "normal" },
            { year: "Skepticism", text: "I critici chiedono prove. Una firma genetica di uno studio potrebbe non funzionare altrove. Bias nella pubblicazione, overfitting, mancanza di validazione clinica: tutte le solite preoccupazioni.", type: "crisis" },
            { year: "2006-2015", text: "Gli studi di validazione si accumulano. Il punteggio viene testato su campioni archiviati di precedenti studi clinici (NSABP B-14, B-20, ATAC). Risultati coerenti tra le coorti. La discriminazione vale.", type: "normal" },
            { year: "2018", text: "TAILORx trial results published: 10,273 women with intermediate Recurrence Scores randomized to chemotherapy vs no chemotherapy. Low scores (0-25) could safely skip chemo. Prospective validation achieved.", type: "revelation" },
            { year: "Impact", text: "Thousands of women spared unnecessary chemotherapy each year. Reduced toxicity, preserved quality of life, saved costs. A prognostic model that EARNED its place in guidelines.", type: "revelation" },
            { year: "Lesson", text: "Oncotype DX succeeded because it was validated relentlessly: retrospective cohorts, prospective trials, multiple populations. Skeptics were answered with data, not marketing. <span class='lesson-gold'>THE LESSON: Trust in prognostic models is earned through validation. Oncotype DX shows what patient-centered, evidence-based model development looks like.</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "10-year distant recurrence risk",
            model: "Oncotype DX 21-gene Recurrence Score",
            discrimination: "Validated across multiple independent cohorts",
            impact: "Changed standard of care; spares thousands from unnecessary chemotherapy"
          },
          hook: "THE HOOK: When Oncotype DX was introduced, it was just another gene signature claiming to predict cancer outcomes. What made it different? Fifteen years of validation. Independent cohorts. Randomized trial evidence. A commercial test that submitted itself to the rigors of science and emerged with guidelines recommending its use. This is how prognostic models should prove themselves."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You've learned about clinical prediction rules. Key lessons: (1) Simplicity enables adoption; (2) Scores work in pathways, not isolation; (3) Purpose (screening vs prognosis) determines required properties; (4) Moderate C-statistics can still be clinically useful if they identify actionable subgroups."
        }
      }
    ]
  },
  {
    id: 6,
    title: "The Reporting",
    subtitle: "TRIPOD Guidelines",
    principle: 5,
    estimatedTime: "20 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Clinical utility trumps statistics"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE HIDDEN PROBLEM: COVID MODELS ‚Äî WHEN URGENCY TRUMPED RIGOR",
          source: "Wynants et al. BMJ 2020 (living review) | COVID prediction models",
          timeline: [
            { year: "Mar 2020", text: "Pandemic begins. Researchers worldwide rush to build COVID prognostic models. Hundreds appear on preprint servers within weeks.", type: "normal" },
            { year: "Wynants Review", text: "La revisione sistematica identifica 232 modelli di previsione COVID entro luglio 2020. Valutazione utilizzando PROBAST (strumento di rischio di bias): 99% ad ALTO rischio di bias.", type: "crisis" },
            { year: "Common Problems", text: "Small samples, data-driven variable selection, no external validation, high risk of overfitting, poorly reported methods, non-reproducible.", type: "crisis" },
            { year: "Reporting Failures", text: "Most papers didn't report: predictor definitions, missing data handling, calibration plots, sample size calculations, or model equations. Impossible to reproduce or implement.", type: "crisis" },
            { year: "Consequence", text: "I medici non potevano utilizzare i modelli: metodi poco chiari, nessun modo di implementarli, nessuno strumento convalidato disponibile quando disperatamente necessario.", type: "crisis" },
            { year: "Lesson", text: "Le linee guida per la segnalazione di TRIPOD esistevano ma sono state ignorate nella fretta. Una segnalazione trasparente non √® un onere burocratico: √® essenziale per l'uso clinico.", type: "revelation" }
          ],
          realData: {
            endpoint: "COVID-19 diagnosis, prognosis, mortality",
            models: "232 models reviewed",
            bias: "229/232 (99%) high risk of bias",
            issue: "Unusable due to poor reporting and methodology"
          },
          hook: "IL GANCIO: nel 2020 sono stati sviluppati 232 modelli di previsione COVID. Il 99% era inutilizzabile a causa di errori e segnalazioni inadeguate. La pandemia aveva un disperato bisogno di strumenti prognostici e abbiamo prodotto rumore invece di segnale. Questo √® il motivo per cui esiste TRIPOD."
        }
      },
      {
        type: 'content',
        content: {
          title: "TRIPOD: Transparent Reporting of Prediction Models",
          sections: [
            {
              heading: "What Is TRIPOD?",
              items: [
                "Linee guida per il reporting per gli studi sui modelli di previsione (2015)",
                "22-item checklist for transparent reporting",
                "Copre sviluppo, validazione e studi combinati",
                "Required by many journals for publication",
                "TRIPOD-AI extension for machine learning models"
              ]
            },
            {
              heading: "Key Reporting Elements:",
              items: [
                "TITLE: Identify as development, validation, or both; name the outcome",
                "PARTICIPANTS: Eligibility criteria, settings, dates, flow diagram",
                "PREDICTORS: Definitions, assessment methods, blinding",
                "OUTCOME: Definition, assessment, timing, blinding",
                "SAMPLE SIZE: Number of participants and events, EPV",
                "MISSING DATA: How much, how handled",
                "MODEL: Full specification (coefficients, baseline risk)",
                "PERFORMANCE: Discrimination AND calibration measures"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: TRIPOD ESSENTIALS",
          title: "What Readers Need to Implement Your Model",
          sections: [
            {
              heading: "Model Specification (Essential!):",
              text: "‚Ä¢ Tutti i predittori con definizioni ‚Ä¢ Coefficienti di regressione o pesi del punteggio ‚Ä¢ Rischio o intercetta di base ‚Ä¢ Istruzioni per il calcolo della probabilit√† prevista ‚Ä¢ Senza questo, il modello non pu√≤ essere UTILIZZATO"
            },
            {
              heading: "Performance Measures:",
              text: "‚Ä¢ Statistica C con IC al 95% ‚Ä¢ Grafico di calibrazione (MOSTRALO) ‚Ä¢ Calibrazione in-the-large e pendenza ‚Ä¢ Sensibilit√†/specificit√† alle soglie pertinenti ‚Ä¢ Analisi della curva decisionale per scopi clinici utilit√†"
            },
            {
              heading: "Flow Diagram:",
              text: "‚Ä¢ Quanti pazienti selezionati, eleggibili, analizzati ‚Ä¢ Motivi di esclusione in ogni fase ‚Ä¢ Numeri con dati mancanti ‚Ä¢ Consente ai lettori di valutare bias di selezione"
            },
            {
              heading: "Missing Data:",
              text: "‚Ä¢ Proporzione mancante per variabile ‚Ä¢ Come sono stati gestiti i dati mancanti ‚Ä¢ Caso completo vs imputazione ‚Ä¢ Analisi di sensibilit√† se √® stata utilizzata l'imputazione"
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'tripod-assessment',
          title: "√à questo documento TRIPOD Conforme?",
          situation: "Stai leggendo un articolo su un nuovo modello di previsione della mortalit√†. Verifica la presenza di elementi chiave TRIPOD.",
          nodes: {
            start: {
              question: "La sezione dei metodi descrive 15 possibili predittori ma non dice quanti erano nel modello finale. Potete implementare questo modello?",
              branches: [
                { text: "S√¨, la metodologia √® chiara", nextNode: "yes_wrong" },
                { text: "No ‚Äî I don't know which predictors are included", nextNode: "no_correct" }
              ]
            },
            yes_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Non √® possibile implementare ci√≤ che non √® possibile definire!",
              text: "Without knowing which predictors are in the final model and their coefficients, you CANNOT calculate predicted probabilities. The paper is incomplete. This is a TRIPOD violation: model specification must be complete.",
              lesson: "TRIPOD requires full model specification: all predictors, all coefficients, intercept/baseline. Without this, the paper is useless for clinical application."
            },
            no_correct: {
              situation: "Correct. You find the supplement with coefficients. Now: the paper reports C = 0.81 but shows no calibration plot.",
              question: "Il reporting delle prestazioni √® adeguato?",
              branches: [
                { text: "Yes ‚Äî C-statistic tells us discrimination", nextNode: "cstat_only_wrong" },
                { text: "No ‚Äî calibration plot is essential", nextNode: "calibration_needed_correct" }
              ]
            },
            cstat_only_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Manca met√† del quadro!",
              text: "C-statistic tells you DISCRIMINATION only. Without a calibration plot, you don't know if predicted probabilities are accurate. A model can have C=0.81 but overestimate risk by 50%. You need BOTH metrics.",
              lesson: "TRIPOD richiede esplicitamente la valutazione della calibrazione. I documenti che riportano solo la statistica C sono incompleti. Richiedi il grafico di calibrazione."
            },
            calibration_needed_correct: {
              situation: "Bene! Richiedete dati di calibrazione supplementari. Infine: il documento riporta la convalida interna tramite bootstrap ma nessuna convalida esterna.",
              question: "Questo modello √® pronto per l'uso clinico?",
              branches: [
                { text: "Yes ‚Äî bootstrap validation is rigorous", nextNode: "internal_only" },
                { text: "No ‚Äî external validation required before clinical use", nextNode: "external_needed_correct" }
              ]
            },
            internal_only: {
              type: 'outcome',
              outcome: 'partial',
              title: "Bootstrap is necessary but not sufficient",
              text: "Bootstrap si adatta all'ottimismo all'interno dei dati di sviluppo. Ma non verifica la GENERALIZZABILIT√Ä a nuove impostazioni. Un modello pu√≤ superare la convalida bootstrap e comunque fallire se distribuito altrove. Prima dell'uso clinico √® necessaria la convalida esterna.",
              lesson: "Development + internal validation = MINIMUM for publication. External validation = MINIMUM for clinical implementation."
            },
            external_needed_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct judgment!",
              text: "Questo documento fornisce uno studio di sviluppo con convalida interna. √à pubblicabile ma NON pronto per la distribuzione clinica. Gli autori dovrebbero dichiarare esplicitamente la necessit√† di una validazione esterna e bisognerebbe attenderla prima di utilizzare il modello clinicamente.",
              lesson: "Be explicit about what a study provides. Development without external validation = hypothesis. External validation = evidence for deployment."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A prediction model paper shows excellent discrimination (C=0.87) and perfect calibration in development data. But it doesn't provide the model equation (coefficients). This paper is:",
          options: [
            { id: 'a', text: "Completo: le prestazioni sono l'informazione chiave", correct: false },
            { id: 'b', text: "Incomplete ‚Äî readers cannot implement or validate the model", correct: true },
            { id: 'c', text: "Acceptable ‚Äî coefficients can be requested from authors", correct: false },
            { id: 'd', text: "Sufficiente per l'implementazione clinica", correct: false }
          ],
          explanation: "Senza coefficienti, il modello non pu√≤ essere implementato, convalidato o utilizzato. \"Contattare gli autori\" non √® accettabile: molti non rispondono e l'implementazione clinica richiede un accesso immediato. TRIPOD richiede le specifiche complete del modello. Questo articolo √® fondamentalmente incompleto."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è THE WARNING: 99% of COVID prediction models were unusable. Not because prognosis was impossible ‚Äî because reporting was inadequate. TRIPOD exists to ensure that prediction models can be implemented, validated, and used. Ignoring reporting standards wastes research and harms patients."
        }
      }
    ]
  },
  {
    id: 7,
    title: "The Utility",
    subtitle: "Decision Curves & Net Benefit",
    principle: 6,
    estimatedTime: "30 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Transparency enables trust"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE MISSING PIECE: WHEN GOOD MODELS DIDN'T HELP PATIENTS",
          source: "Vickers & Elkin 2006 | Medical Decision Making | Decision curve analysis",
          timeline: [
            { year: "Classic Era", text: "Prognostic models evaluated by C-statistic and calibration. 'Good' models (C>0.75, calibrated) assumed to be clinically useful. No direct measurement of utility.", type: "normal" },
            { year: "The Problem", text: "Many models with good statistics didn't change decisions or outcomes. Example: A model that classifies everyone as high-risk has C=0.50 but perfect 'sensitivity.' Statistics can be gamed.", type: "crisis" },
            { year: "2006", text: "Vickers ed Elkin introducono l'analisi della curva decisionale (DCA). Misura direttamente il BENEFICIO NETTO: utilizzando il modello sono pi√π i pazienti aiutati che danneggiati?", type: "revelation" },
            { year: "Key Insight", text: "Clinical utility depends on TREATMENT THRESHOLD ‚Äî how bad is it to miss a case vs unnecessarily treat? Different thresholds, different utility assessments.", type: "revelation" },
            { year: "Adoption", text: "DCA ora richiesto da molte riviste. La FDA considera le curve decisionali per l'approvazione del dispositivo diagnostico. Passaggio da \"buone statistiche\" a \"valore clinico\".", type: "revelation" },
            { year: "Lesson", text: "Discrimination and calibration are necessary but not sufficient. The ultimate question: Does using this model lead to better decisions than not using it?", type: "revelation" }
          ],
          realData: {
            endpoint: "Decision-making improvement",
            method: "Net benefit calculation",
            comparison: "Model vs treat-all vs treat-none",
            impact: "Now standard in major journals"
          },
          hook: "THE HOOK: A model can have C=0.85 and perfect calibration but provide ZERO clinical benefit if it doesn't change appropriate decisions. Decision curves answer: 'Does this model help patients compared to simpler strategies?' This is the question that actually matters."
        }
      },
      {
        type: 'content',
        content: {
          title: "What Is Net Benefit?",
          sections: [
            {
              heading: "The Core Concept:",
              text: "Il beneficio netto pesa i VERI POSITIVI (pazienti correttamente identificati per il trattamento) rispetto ai FALSI POSITIVI (pazienti trattati inutilmente), aggiustato per il danno di un trattamento non necessario."
            },
            {
              heading: "The Formula:",
              text: "Net Benefit = (True Positives / N) - (False Positives / N) √ó (threshold / (1 - threshold))"
            },
            {
              heading: "Treatment Threshold:",
              items: [
                "La probabilit√† al di sopra della quale tratteresti",
                "Reflects tradeoff: harm of missing case vs harm of unnecessary treatment",
                "Low threshold (5%): treat-all may be reasonable",
                "High threshold (30%): only treat clear high-risk patients"
              ]
            },
            {
              heading: "Comparators:",
              items: [
                "TREAT ALL: Give treatment to everyone (net benefit = outcome rate - FP penalty)",
                "TREAT NONE: Give treatment to no one (net benefit = 0)",
                "MODEL: Use model to select patients (should beat both alternatives)"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: LETTURA DI UNA CURVA DECISIONALE",
          title: "How to Interpret Decision Curve Analysis",
          sections: [
            {
              heading: "X-Axis: Threshold Probability",
              text: "The treatment threshold ‚Äî probability above which you'd treat. Low thresholds (left) = aggressive treatment. High thresholds (right) = conservative treatment."
            },
            {
              heading: "Y-Axis: Net Benefit",
              text: "Pi√π alto √®, meglio √®. Rappresenta \"veri positivi meno falsi positivi ponderati\". Il modello con il beneficio netto pi√π alto alla soglia √® il migliore."
            },
            {
              heading: "Key Curves:",
              text: "‚Ä¢ TREAT ALL: Usually a downward slope (more FPs as threshold rises)\n‚Ä¢ TREAT NONE: Flat line at 0\n‚Ä¢ MODEL: Should be ABOVE both treat-all and treat-none in useful threshold range"
            },
            {
              heading: "Interpretation:",
              items: [
                "Model above treat-all AND treat-none = useful",
                "Model matches treat-all = model adds nothing",
                "Model below treat-none = model causes harm",
                "Focus on CLINICALLY RELEVANT threshold range"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'decision-curve-interpretation',
          title: "Reading a Decision Curve",
          situation: "A decision curve shows a model for predicting 30-day readmission. At threshold 0.10: Model net benefit = 0.05, Treat-all = 0.04, Treat-none = 0. At threshold 0.30: Model net benefit = 0.02, Treat-all = -0.05, Treat-none = 0.",
          nodes: {
            start: {
              question: "At threshold 0.10 (intervene if risk >10%), is the model useful?",
              branches: [
                { text: "Yes ‚Äî model has highest net benefit (0.05 > 0.04 > 0)", nextNode: "threshold10_correct" },
                { text: "Barely ‚Äî model only slightly better than treat-all", nextNode: "threshold10_partial" }
              ]
            },
            threshold10_correct: {
              situation: "Correct ‚Äî at 10% threshold, the model provides slightly more net benefit than treating everyone. Now consider threshold 0.30:",
              question: "At threshold 0.30 (intervene only if risk >30%), what's the best strategy?",
              branches: [
                { text: "Model ‚Äî net benefit 0.02 is positive", nextNode: "model30_correct" },
                { text: "Treat-none ‚Äî model benefit is tiny", nextNode: "treatnone_partial" }
              ]
            },
            threshold10_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Il margine √® importante dal punto di vista clinico",
              text: "Net benefit 0.05 vs 0.04 is indeed small. But over thousands of patients, even small improvements accumulate. The key question: Is the difference CLINICALLY meaningful and worth the implementation effort?",
              lesson: "Small net benefit improvements can still be worthwhile at scale. But weigh against implementation costs."
            },
            model30_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct reading!",
              text: "At threshold 0.30: Model (0.02) > Treat-none (0) > Treat-all (-0.05). The model provides positive net benefit when we're conservative about intervention. Importantly, treat-all is now HARMFUL (negative net benefit) ‚Äî intervening on everyone at high threshold wastes resources on false positives.",
              lesson: "Decision curves show WHEN a model is useful. This model helps at both thresholds but especially at higher thresholds where treat-all fails."
            },
            treatnone_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "The model is still better than nothing",
              text: "Il beneficio netto di 0,02 √® piccolo ma positivo. Non trattare nessuno ha 0 benefici. Se l‚Äôintervento presenta benefici significativi con costi accettabili, vale comunque la pena utilizzare il modello. Un 'piccolo vantaggio' √® pur sempre un vantaggio.",
              lesson: "Don't dismiss small positive net benefits. But do consider: Is the benefit large enough to justify implementation?"
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A model's decision curve shows it has LOWER net benefit than 'treat all' at thresholds below 15%, but HIGHER net benefit above 15%. This model:",
          options: [
            { id: 'a', text: "Is useless ‚Äî it doesn't beat treat-all at low thresholds", correct: false },
            { id: 'b', text: "Is useful for conservative decision-makers (threshold >15%) but not aggressive ones", correct: true },
            { id: 'c', text: "Has poor discrimination", correct: false },
            { id: 'd', text: "Is poorly calibrated", correct: false }
          ],
          explanation: "Different thresholds reflect different clinical philosophies. If your threshold is >15% (conservative), use the model. If your threshold is <15% (aggressive), just treat everyone ‚Äî the model doesn't help. Clinical utility is THRESHOLD-SPECIFIC."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You've learned that clinical utility matters more than statistical performance. Decision curve analysis directly measures whether a model improves decisions. A model with modest C-statistic but positive net benefit is more valuable than a 'perfect' model that doesn't change appropriate care."
        }
      }
    ]
  },
  {
    id: 8,
    title: "The Bias",
    subtitle: "PROBAST Assessment",
    principle: 1,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "A model is only as good as its validation"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE AI MIRAGE: CHEST X-RAY MODELS ‚Äî WHEN SHORTCUTS FOOLED EVERYONE",
          source: "Zech et al. PLOS Med 2018 | DeGrave et al. Nat Mach Intell 2021 | COVID CXR",
          timeline: [
            { year: "2017-18", text: "Deep learning models achieve 'radiologist-level' performance detecting pneumonia on chest X-rays. C-statistics >0.90. Major publications.", type: "normal" },
            { year: "2018", text: "Zech et al. mostrare che i modelli apprendono i MARCATORI OSPEDALIERI (non la malattia). Le prestazioni scendono a C ~0,60 se testate su immagini di diversi ospedali. I modelli hanno appreso i timbri del dipartimento, non la polmonite.", type: "crisis" },
            { year: "2020", text: "COVID CXR models proliferate. Claims of 95%+ accuracy. Deployed in some hospitals without rigorous validation.", type: "normal" },
            { year: "2021", text: "DeGrave et al. show COVID models used SHORTCUTS: patient positioning (COVID patients were sicker, positioned differently), image artifacts, and laterality markers. Not actual COVID lung findings.", type: "crisis" },
            { year: "Root Cause", text: "I dati di addestramento presentavano CORRELAZIONI SPURE. I confondenti erano pi√π facili da apprendere rispetto alla patologia vera e propria. Le elevate \"prestazioni\" interne erano un'illusione.", type: "revelation" },
            { year: "Lesson", text: "I modelli ML trovano modelli, non necessariamente i modelli GIUSTI. La convalida esterna in diversi contesti √® essenziale. Le \"prestazioni dell'intelligenza artificiale\" senza una valutazione dei bias non hanno senso.", type: "revelation" }
          ],
          realData: {
            endpoint: "Pneumonia/COVID detection",
            claimed: "C-statistic >0.90",
            external: "C-statistic ~0.60 (different hospitals)",
            mechanism: "Learned hospital markers, patient positioning ‚Äî not disease"
          },
          hook: "THE HOOK: AI models 'outperformed radiologists' ‚Äî by learning what hospital the image came from, not what disease the patient had. This is why PROBAST and systematic bias assessment exist. High numbers mean nothing if the model learned the wrong things."
        }
      },
      {
        type: 'content',
        content: {
          title: "PROBAST: Prediction Model Risk of Bias Assessment Tool",
          sections: [
            {
              heading: "What Is PROBAST?",
              items: [
                "Strumento approvato da Cochrane per valutare i bias negli studi sui modelli di previsione",
                "Assesses RISK OF BIAS and APPLICABILITY concerns",
                "20 signaling questions across 4 domains",
                "Used in systematic reviews of prognostic models"
              ]
            },
            {
              heading: "Four Domains:",
              items: [
                "1. PARTICIPANTS: Appropriate enrollment, representative population",
                "2. PREDICTORS: Defined clearly, measured consistently, available at prediction time",
                "3. OUTCOME: Defined clearly, measured accurately, appropriate time horizon",
                "4. ANALYSIS: Adequate sample size, appropriate handling of missing data, proper validation"
              ]
            },
            {
              heading: "Overall Judgment:",
              text: "HIGH risk of bias if ANY domain is high risk. Like ROBINS-I, PROBAST is intentionally strict. One fatal flaw = study is unreliable."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'probast-assessment',
          title: "PROBAST in Practice",
          situation: "You're reviewing a COVID mortality model. The study: (1) Used hospitalized patients from one NYC hospital in April 2020; (2) Predictors included 45 variables, selected by significance testing; (3) Outcome was in-hospital death, well-defined; (4) 500 patients, 150 deaths, internal validation by bootstrap only.",
          nodes: {
            start: {
              question: "Assess the PARTICIPANTS domain:",
              branches: [
                { text: "Low risk ‚Äî all hospitalized COVID patients included", nextNode: "participants_low" },
                { text: "High risk ‚Äî one hospital, peak pandemic, selection concerns", nextNode: "participants_high" }
              ]
            },
            participants_high: {
              situation: "Good judgment. Single NYC hospital during peak means: (1) severe cases overrepresented, (2) overwhelmed system, (3) unique local practices. Now assess ANALYSIS domain:",
              question: "Lo studio ha testato 45 variabili con 150 eventi. Qual √® l'EPV?",
              branches: [
                { text: "150/45 = 3.3 ‚Äî critically low, high risk of overfitting", nextNode: "epv_correct" },
                { text: "La convalida Bootstrap corregge questo problema: rischio medio", nextNode: "bootstrap_wrong" }
              ]
            },
            participants_low: {
              type: 'outcome',
              outcome: 'partial',
              title: "Considera i problemi di generalizzabilit√†",
              text: "While all hospitalized patients were included, a single NYC hospital during peak pandemic has unique features: extreme case severity, overwhelmed resources, specific treatment protocols. External populations will differ substantially.",
              lesson: "PROBAST valuta sia BIAS (validit√† interna) che APPLICABILIT√Ä (validit√† esterna). Anche se imparziale, un modello potrebbe non essere applicabile altrove."
            },
            epv_correct: {
              situation: "Exactly! EPV of 3.3 is critically low. Now: the authors report C-statistic of 0.88 after bootstrap validation.",
              question: "Does the high C-statistic indicate a good model?",
              branches: [
                { text: "S√¨: bootstrap corretto per ottimismo e C √® ancora alto", nextNode: "cstat_high_wrong" },
                { text: "No ‚Äî with EPV 3.3, even bootstrap can't fix overfitting; this C is likely inflated", nextNode: "cstat_skeptic_correct" }
              ]
            },
            bootstrap_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Bootstrap cannot fix inadequate sample size!",
              text: "Bootstrap stima che OPTIMISM si adatti eccessivamente ai dati di sviluppo. Ma con un EPV di 3,3, il modello adatta il RUMORE anzich√© il segnale. Bootstrap mostrer√† un certo ottimismo ma non potr√† rivelare che il modello √® fondamentalmente non valido.",
              lesson: "Bootstrap corregge l'overfitting noto. Non pu√≤ salvare un modello con dimensioni del campione fondamentalmente inadeguate."
            },
            cstat_high_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "This C-statistic is almost certainly unreliable!",
              text: "With EPV 3.3 and 45 variables selected by significance testing, the model has absorbed massive amounts of noise. Bootstrap helps but cannot fully correct this. The true external C is likely 0.65-0.75 at best. High internal C with low EPV = red flag.",
              lesson: "When EPV is very low, internal metrics (even bootstrap-corrected) are unreliable. Only external validation reveals true performance."
            },
            cstat_skeptic_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Excellent critical appraisal!",
              text: "You correctly identified: (1) Participant concerns from single-site pandemic peak; (2) Analysis concerns from EPV 3.3; (3) Skepticism of high C despite statistical correction. This study has HIGH risk of bias in multiple domains. PROBAST overall: HIGH RISK.",
              lesson: "PROBAST requires domain-by-domain assessment. Multiple high-risk domains = study should not inform clinical practice without external validation."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A PROBAST assessment shows: Participants LOW, Predictors LOW, Outcome LOW, Analysis HIGH (inadequate sample size). The overall risk of bias is:",
          options: [
            { id: 'a', text: "Low ‚Äî 3 of 4 domains are low risk", correct: false },
            { id: 'b', text: "Medium ‚Äî mostly low with one concern", correct: false },
            { id: 'c', text: "High ‚Äî one high-risk domain makes overall high", correct: true },
            { id: 'd', text: "Unclear ‚Äî need to average the domains", correct: false }
          ],
          explanation: "Come ROBINS-I, PROBAST utilizza il principio dell'anello pi√π debole. Se QUALSIASI dominio √® ad alto rischio, lo studio complessivo √® ad alto rischio. Non si calcola la media n√© si vota: un difetto critico invalida lo studio. Questo √® intenzionalmente conservativo perch√© un modello con un grosso problema √® inaffidabile."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è THE WARNING: The chest X-ray AI debacle shows that impressive performance numbers can be completely artifactual. Models learn whatever predicts the outcome ‚Äî including confounders, shortcuts, and spurious correlations. PROBAST systematically checks whether a model learned the RIGHT things for the RIGHT reasons."
        }
      }
    ]
  },
  {
    id: 9,
    title: "L'apprendimento automatico",
    subtitle: "ML vs Regression",
    principle: 3,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Pi√π predittori non sono migliori"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE MODEST TRUTH: ML vs LOGISTIC REGRESSION ‚Äî WHEN COMPLEXITY DIDN'T PAY",
          source: "Christodoulou et al. 2019 | J Clin Epidemiol | Systematic review",
          timeline: [
            { year: "2010s", text: "L'hype sull'apprendimento automatico raggiunge la medicina. Afferma che il deep learning, le foreste casuali e le reti neurali rivoluzioneranno la previsione. 'Le statistiche tradizionali sono obsolete.'", type: "normal" },
            { year: "2019", text: "Christodoulou et al. systematic review: 71 studies directly comparing ML to logistic regression for clinical prediction. Same data, same outcomes.", type: "normal" },
            { year: "The Results", text: "ML outperformed logistic regression in... 24% of studies. Logistic regression outperformed ML in 10%. No significant difference in 66%. Median C-statistic difference: 0.00.", type: "revelation" },
            { year: "Why?", text: "Per i dati clinici tabellari con dimensionalit√† moderata, la regressione logistica cattura la maggior parte dei segnali. I vantaggi della ML emergono con immagini, sequenze e dimensioni molto elevate, non tipici predittori clinici.", type: "revelation" },
            { year: "The Cost", text: "I modelli ML sono meno interpretabili, pi√π difficili da implementare, pi√π inclini all'adattamento eccessivo su set di dati di piccole dimensioni e richiedono pi√π risorse computazionali. Complessit√† senza beneficio.", type: "crisis" },
            { year: "Lesson", text: "Scegli i metodi in base al problema, non all'hype. Per la maggior parte delle attivit√† di previsione clinica, la regressione logistica √® competitiva con la ML e pi√π pratica.", type: "revelation" }
          ],
          realData: {
            endpoint: "Various clinical outcomes",
            comparison: "71 ML vs logistic regression comparisons",
            result: "Median AUC difference: 0.00",
            winner: "Nessuna differenza significativa nel 66% degli studi"
          },
          hook: "THE HOOK: The systematic comparison showed ML and logistic regression perform EQUALLY for most clinical prediction. ML wins in specific domains (imaging, sequences) but not for standard clinical data. Don't use complexity when simplicity works."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "REAL-WORLD CASE: THE COVID SEVERITY SCORES RACE ‚Äî WHEN SPEED DEFEATED RIGOR",
          source: "Wynants et al. BMJ 2020 (revisione sistematica vivente) | Studio ISARIC 4C | Modelli di previsione COVID-19",
          timeline: [
            { year: "Early 2020", text: "COVID-19 pandemic begins. Clinicians desperately need tools to predict which patients will deteriorate. Researchers worldwide rush to develop prognostic models.", type: "normal" },
            { year: "March-June 2020", text: "Oltre 100 modelli prognostici COVID pubblicati in soli quattro mesi. Apprendimento automatico, regressione logistica, reti neurali: ogni metodo utilizzato. Server di inondazione di prestamp.", type: "normal" },
            { year: "The Review", text: "Wynants et al. systematic review: Of 107 models evaluated, nearly ALL were at high risk of bias. Small samples, no external validation, overfitting to local populations, outcome data that hadn't matured.", type: "crisis" },
            { year: "Common Flaws", text: "Campioni non rappresentativi (casi di pandemia iniziale). Accertamento degli esiti durante la malattia acuta. Gestione inappropriata dei dati mancanti. Nessuna convalida temporale o geografica. Modelli sintonizzati sul rumore, non sul segnale.", type: "crisis" },
            { year: "The Exceptions", text: "A few models (4C Mortality Score, ISARIC) were developed properly: large datasets (tens of thousands), multiple sites, external validation across countries. These took LONGER but actually worked.", type: "revelation" },
            { year: "Lesson", text: "Urgent need doesn't justify methodological shortcuts. Most rushed COVID models were useless ‚Äî or worse, misleading. The rigorous models that took time to develop properly were the ones that actually helped. <span class='lesson-gold'>THE LESSON: In a crisis, there's enormous pressure to 'do something.' But a bad model isn't better than no model. Speed without rigor produces predictions that can't be trusted when trust matters most.</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "COVID-19 mortality or deterioration",
            models: ">100 published in 4 months",
            quality: "Nearly all at high risk of bias",
            validated: "Only handful properly externally validated"
          },
          hook: "THE HOOK: The COVID pandemic was a natural experiment in rapid model development. The result? Quantity did not equal quality. Over 100 models, nearly all useless. A handful of properly developed models (4C, ISARIC) required large multinational cohorts and careful validation. There are no shortcuts to good prognostic modeling, even in an emergency."
        }
      },
      {
        type: 'content',
        content: {
          title: "When Does ML Actually Help?",
          sections: [
            {
              heading: "ML Advantages:",
              items: [
                "Dati ad alta dimensionalit√† (genomica, proteomica)",
                "Image data (radiology, pathology, dermatology)",
                "Sequential/temporal data (ECGs, time series)",
                "Complex non-linear interactions (rare in clinical prediction)",
                "Very large datasets (>100,000 samples)"
              ]
            },
            {
              heading: "Logistic Regression Advantages:",
              items: [
                "Interpretable coefficients",
                "Handles small samples better (with penalization)",
                "Pi√π facile da implementare e distribuire",
                "Explicit uncertainty quantification",
                "Propriet√† e diagnostica ben comprese"
              ]
            },
            {
              heading: "The Decision Framework:",
              text: "If your data is tabular with <50 predictors and <10,000 samples, start with penalized logistic regression. Try ML if you have specific reasons (non-linearity, interactions, high dimensions). Compare fairly (same data, same validation)."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'ml-vs-regression',
          title: "Should You Use Machine Learning?",
          situation: "You're developing a 30-day mortality model for heart failure patients. You have: 2,000 patients, 200 deaths, 25 candidate predictors (demographics, labs, vitals), structured EHR data. A colleague insists you use deep learning because it's 'state of the art.'",
          nodes: {
            start: {
              question: "Cos'√® l'EPV per un Modello a 25 predittori?",
              branches: [
                { text: "200/25 = 8 ‚Äî marginal for any method", nextNode: "epv_marginal" },
                { text: "Molti dati per il deep learning", nextNode: "plenty_wrong" }
              ]
            },
            epv_marginal: {
              situation: "Correct ‚Äî EPV of 8 is marginal. Deep learning typically needs MORE data than logistic regression to avoid overfitting.",
              question: "Dati i dati limitati, qual √® il tuo approccio?",
              branches: [
                { text: "Use deep learning but with regularization", nextNode: "dl_regularize_partial" },
                { text: "Use penalized logistic regression (LASSO/ridge)", nextNode: "penalized_correct" }
              ]
            },
            plenty_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Il deep learning ha bisogno di PI√ô dati, non di meno!",
              text: "Il deep learning ha milioni di parametri. Con 2.000 pazienti e 200 eventi, una rete neurale si adatter√† enormemente. Questo √® esattamente il contesto in cui la regressione logistica supera il machine learning. I vincoli relativi alle dimensioni del campione FAVORISCONO metodi pi√π semplici.",
              lesson: "ML/DL eccelle grazie ai big data. Con dati limitati, i modelli pi√π semplici con meno parametri generalizzano meglio."
            },
            dl_regularize_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Regularization helps but doesn't fully solve the problem",
              text: "√à possibile applicare il dropout, il decadimento del peso e l'arresto anticipato. Ma il deep learning con 200 eventi √® in salita. Anche le reti neurali ben regolarizzate hanno difficolt√† con campioni piccoli. √à probabile che la regressione logistica con LASSO funzioni altrettanto bene o meglio con meno sforzo.",
              lesson: "Regularization is essential but doesn't overcome fundamental sample size limitations for complex models."
            },
            penalized_correct: {
              situation: "Good choice! Now: Your logistic regression model achieves C = 0.78. A vendor offers a proprietary ML model claiming C = 0.82 on similar populations.",
              question: "Dovresti passare al modello ML del fornitore?",
              branches: [
                { text: "Yes ‚Äî 0.82 > 0.78, and ML is more sophisticated", nextNode: "switch_wrong" },
                { text: "No ‚Äî demand external validation on YOUR population first", nextNode: "validation_first_correct" }
              ]
            },
            switch_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Remember Epic Sepsis!",
              text: "Vendor-reported metrics are often inflated. A 0.04 difference in C-statistic is within noise. Without validation on YOUR population, you don't know if the ML model works in your context. Plus: Can you interpret it? Debug it? Trust it?",
              lesson: "Non adottare mai modelli basati sulle affermazioni del fornitore. Richiedi una convalida indipendente sui dati rappresentativi della tua impostazione."
            },
            validation_first_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Evidence-based skepticism!",
              text: "Hai correttamente richiesto la convalida prima dell'adozione. La differenza di 0,04 della statistica C (0,78 vs 0,82) √® probabilmente rumore. Anche se reale, potrebbe non tradursi in una migliore utilit√† clinica. Il tuo modello logistico interpretabile potrebbe essere pi√π sicuro e pi√π facile da implementare.",
              lesson: "Prefer simpler models unless complexity provides clear, validated, clinically meaningful benefit."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A radiology department wants to implement an AI model for detecting pneumonia on chest X-rays. The model was trained and validated at Stanford with C = 0.92. Before deploying at your community hospital, you should:",
          options: [
            { id: 'a', text: "Deploy immediately ‚Äî Stanford is a top institution", correct: false },
            { id: 'b', text: "Validate on a sample of your hospital's images first", correct: true },
            { id: 'c', text: "Attendere l'approvazione della FDA", correct: false },
            { id: 'd', text: "Use it only for patients similar to Stanford's population", correct: false }
          ],
          explanation: "I modelli di intelligenza artificiale per radiologia sono notoriamente sensibili ai protocolli di acquisizione, alle apparecchiature, alle popolazioni di pazienti e alla qualit√† delle immagini. Un modello addestrato a Stanford potrebbe aver appreso le caratteristiche specifiche di Stanford. La convalida locale √® essenziale prima dell'implementazione: i fallimenti dell'intelligenza artificiale dei raggi X del torace lo hanno dimostrato."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You've learned that ML isn't magic. For tabular clinical data, logistic regression often matches ML performance with better interpretability. ML advantages emerge with images, sequences, or very large datasets. Choose methods based on your data and problem, not hype. Always validate before deployment."
        }
      }
    ]
  },
  {
    id: 10,
    title: "The Implementation",
    subtitle: "Dal modello alla pratica",
    principle: 5,
    estimatedTime: "20 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Clinical utility trumps statistics"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE IMPLEMENTATION GAP: CURB-65 ‚Äî WHEN A GOOD MODEL GATHERED DUST",
          source: "Implementation science literature | Pneumonia severity scores | Clinical workflow",
          timeline: [
            { year: "2003", text: "CURB-65 published for pneumonia severity assessment. Beautifully simple: 5 items, integer points, validated. C-statistic ~0.75 for mortality.", type: "normal" },
            { year: "Development", text: "Confusion, Urea >7, Respiratory rate ‚â•30, BP low, Age ‚â•65. Score 0-1 = outpatient. Score 2 = consider admission. Score 3-5 = ICU.", type: "normal" },
            { year: "The Problem", text: "Widespread publication didn't mean widespread use. Studies showed CURB-65 used in <50% of pneumonia admissions. Clinicians continued using gestalt.", type: "crisis" },
            { year: "Barriers", text: "Non integrato nel flusso di lavoro. Nessuna richiesta di EHR. Richiede la ricerca di criteri. Non si sente necessario quando \"posso capire chi √® malato\". Inerzia clinica.", type: "crisis" },
            { year: "Soluzioni che hanno funzionato", text: "EHR auto-calculation, mandatory documentation, clinical decision support alerts. When CURB-65 was EMBEDDED in workflow, usage increased dramatically.", type: "revelation" },
            { year: "Lesson", text: "A valid model that isn't USED is worthless. Implementation requires: EHR integration, workflow fit, clinician buy-in, and often, mandatory documentation.", type: "revelation" }
          ],
          realData: {
            endpoint: "30-day mortality in pneumonia",
            model: "CURB-65",
            discrimination: "C-statistic ~0.75",
            usage: "<50% before implementation interventions"
          },
          hook: "THE HOOK: CURB-65 was published in 2003. Twenty years later, it's still underused in many hospitals. A prediction model is only as good as its implementation. The final mile ‚Äî from validation to bedside ‚Äî is often the hardest."
        }
      },
      {
        type: 'content',
        content: {
          title: "Implementation Barriers",
          sections: [
            {
              heading: "Clinician Factors:",
              items: [
                "Awareness: Don't know the score exists",
                "Agreement: Don't believe it adds value over clinical judgment",
                "Self-efficacy: Don't know how to use it",
                "Outcome expectancy: Don't expect it to improve patient outcomes",
                "Inertia: Existing practice works 'well enough'"
              ]
            },
            {
              heading: "System Factors:",
              items: [
                "No EHR integration ‚Äî requires separate calculation",
                "Workflow disruption ‚Äî extra steps, extra time",
                "No feedback ‚Äî clinicians don't see if score helped",
                "No accountability ‚Äî no tracking of score use",
                "Alert fatigue ‚Äî if auto-calculated, may be ignored"
              ]
            },
            {
              heading: "Model Factors:",
              items: [
                "Complexity ‚Äî can't remember the criteria",
                "Requisiti di dati: predittori non raccolti di routine",
                "Unclear thresholds ‚Äî what action for what score?",
                "Lack of local validation ‚Äî doesn't feel applicable"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: IMPLEMENTAZIONE DI SUCCESSO",
          title: "How to Get Models Into Practice",
          sections: [
            {
              heading: "1. Choose the Right Model:",
              text: "‚Ä¢ Simple enough to use (or auto-calculate)\n‚Ä¢ Validated in similar population\n‚Ä¢ Clear action thresholds\n‚Ä¢ Addresses a real clinical need"
            },
            {
              heading: "2. Integrate Into Workflow:",
              text: "‚Ä¢ Integrato nell'EHR (calcolo automatico quando possibile) ‚Ä¢ Trigger nei momenti clinici appropriati ‚Ä¢ Visualizzare i risultati dove vengono prese le decisioni ‚Ä¢ Ridurre al minimo l'immissione di dati aggiuntivi"
            },
            {
              heading: "3. Provide Decision Support:",
              text: "‚Ä¢ Tradurre il punteggio in azione raccomandata ‚Ä¢ Spiegare la raccomandazione (perch√© questo punteggio suggerisce questa azione) ‚Ä¢ Consentire l'override con la documentazione ‚Ä¢ Non fornire solo un numero: fornire una guida"
            },
            {
              heading: "4. Monitor and Feedback:",
              text: "‚Ä¢ Track score usage rates\n‚Ä¢ Monitor patient outcomes\n‚Ä¢ Provide feedback to clinicians\n‚Ä¢ Iterate and improve"
            }
          ]
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "REAL-WORLD CASE: THE EPIC DETERIORATION INDEX ‚Äî TECHNICALLY VALID, CLINICALLY FRUSTRATED",
          source: "Epic Systems implementation studies | Alert fatigue literature | Clinical workflow research",
          timeline: [
            { year: "Development", text: "Epic's Deterioration Index is developed to predict patient decline 6-12 hours before clinical recognition. The algorithm analyzes vital signs, lab trends, nursing assessments. Technically sophisticated.", type: "normal" },
            { year: "Deployment", text: "Gli ospedali si affrettano a implementare l'indice di deterioramento. La promessa: allarme tempestivo del declino del paziente. Infermieri e medici verranno allertati prima che i pazienti si schiantino. Le vite verranno salvate.", type: "normal" },
            { year: "Reality Check", text: "Gli studi rivelano problemi. Molti allarmi vengono lanciati su pazienti che GI√Ä ricevono cure adeguate: l‚Äôinfermiera sa che il paziente √® malato. L'avviso aggiunge rumore, non segnale.", type: "crisis" },
            { year: "Alert Fatigue", text: "Clinicians receive dozens of alerts daily. Most are for patients already being managed. The 'cry wolf' effect sets in: alerts are ignored, dismissed without review, treated as background noise.", type: "crisis" },
            { year: "The Gap", text: "The model WORKS ‚Äî it identifies deteriorating patients. But identification isn't the bottleneck. The question is: what can clinicians DO differently? If the patient is already on telemetry, already receiving fluids, already being watched ‚Äî the alert provides no new action.", type: "revelation" },
            { year: "Lesson", text: "A prognostic model deployed without actionability is just noise. The Deterioration Index failed not because it couldn't predict ‚Äî but because prediction without clear, novel intervention is useless at the bedside. <span class='lesson-gold'>THE LESSON: Implementation requires more than accurate prediction. It requires: actionable thresholds, novel information, clear interventions, and workflow integration. Prediction without actionability is just sophisticated interruption.</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "Patient deterioration",
            model: "Epic Deterioration Index",
            problem: "Alert fatigue from non-actionable predictions",
            barrier: "Predictions often confirmed what clinicians already knew"
          },
          hook: "THE HOOK: The Epic Deterioration Index is a case study in implementation failure. The model wasn't wrong ‚Äî it successfully identified deteriorating patients. But the alerts often told clinicians what they already knew, for patients already receiving appropriate care. Prediction needs a purpose: if knowing the score doesn't change what you do, the score is just noise."
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'implementation-strategy',
          title: "Planning Implementation",
          situation: "Your hospital wants to implement a sepsis prediction model. The model requires: lactate level, vital signs, and WBC count. It outputs a probability of sepsis. You need to design the implementation.",
          nodes: {
            start: {
              question: "In quale punto del flusso di lavoro clinico dovrebbe attivarsi il modello?",
              branches: [
                { text: "When a patient is admitted to any unit", nextNode: "admission_trigger" },
                { text: "When vital signs suggest possible deterioration (SIRS-like)", nextNode: "vital_trigger_correct" },
                { text: "Every 4 hours automatically for all inpatients", nextNode: "regular_trigger_partial" }
              ]
            },
            admission_trigger: {
              type: 'outcome',
              outcome: 'partial',
              title: "Considerare il contesto clinico",
              text: "Admission is one trigger point, but sepsis can develop DURING hospitalization. A patient admitted for elective surgery who develops sepsis on day 3 wouldn't be captured. Consider continuous or recurrent triggering.",
              lesson: "Abbina i punti di attivazione al momento in cui si sviluppa la sepsi, non solo al momento in cui i pazienti entrano in ospedale."
            },
            vital_trigger_correct: {
              situation: "Buono: l'attivazione in caso di deterioramento clinico cattura i casi di nuova insorgenza. Ora: il modello si attiva e prevede una probabilit√† di sepsi del 45%. Cosa dovrebbe mostrare l'avviso?",
              question: "Alert design:",
              branches: [
                { text: "'Sepsis probability 45%' ‚Äî let clinician decide", nextNode: "probability_only_partial" },
                { text: "'Moderate sepsis risk ‚Äî consider: lactate, blood cultures, antibiotics' with order set link", nextNode: "actionable_correct" }
              ]
            },
            regular_trigger_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Beware alert fatigue!",
              text: "Il calcolo ogni 4 ore per tutti i pazienti ricoverati generer√† un numero enorme di avvisi, la maggior parte per i pazienti a basso rischio. I medici impareranno a ignorarli (fatica da allerta). L'attivazione mirata √® pi√π efficace.",
              lesson: "Implementation must balance sensitivity against clinician burden. Alert fatigue is a real implementation failure mode."
            },
            probability_only_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Probabilities alone don't drive action",
              text: "Clinicians don't know what to DO with '45%.' Is that high? What action is warranted? Best practice: translate probability to risk category and link to specific recommended actions (orders, consults).",
              lesson: "Il supporto alle decisioni cliniche dovrebbe essere ATTUABILE. Un numero non √® un supporto decisionale: le raccomandazioni con azioni collegate lo sono."
            },
            actionable_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Ci√≤ guida l'azione appropriata!",
              text: "Risk category + specific recommendations + order set link = actionable decision support. The clinician sees the warning, understands the risk level, knows what to do, and can act immediately. This is how models change behavior.",
              lesson: "Implementation success requires: right trigger, clear recommendation, actionable orders. Make the right thing the easy thing."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A hospital implements a readmission prediction model. Alerts fire frequently, but readmission rates don't improve. The most likely explanation is:",
          options: [
            { id: 'a', text: "The model has poor discrimination", correct: false },
            { id: 'b', text: "Alerts aren't linked to effective interventions", correct: true },
            { id: 'c', text: "Il modello √® scarsamente calibrato", correct: false },
            { id: 'd', text: "Clinicians don't trust the model", correct: false }
          ],
          explanation: "La previsione senza un intervento efficace non migliora i risultati. Se l'allarme dice ‚Äúelevato rischio di riammissione‚Äù ma non esiste un'azione chiara ed efficace per ridurre tale rischio, l'allarme √® solo rumore. L'implementazione deve collegare la previsione agli interventi che funzionano realmente."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è THE WARNING: Most validated models never reach clinical practice. Those that do often fail to improve outcomes ‚Äî not because the model is wrong, but because implementation is poor. The final step ‚Äî embedding prediction into action ‚Äî is where many projects fail."
        }
      }
    ]
  },
  {
    id: 11,
    title: "The Capstone",
    subtitle: "Full Model Evaluation",
    principle: null,
    estimatedTime: "30 min",
    slides: [
      {
        type: 'title',
        content: {
          title: "The Capstone",
          subtitle: "Evaluating a Prognostic Model",
          text: "Apply everything you've learned to critically evaluate a real prognostic model study."
        }
      },
      {
        type: 'content',
        content: {
          title: "Capstone Exercise: The COVID Mortality Model",
          sections: [
            {
              heading: "The Study:",
              text: "Un documento presenta un modello di apprendimento automatico per prevedere la mortalit√† da COVID-19. Affermazioni: \"Il nostro modello XGBoost raggiunge una statistica C di 0,91 e rivoluzioner√† il triage COVID.\""
            },
            {
              heading: "Study Details:",
              items: [
                "Data: 3,000 hospitalized COVID patients from one NYC hospital, March-May 2020",
                "Outcome: In-hospital mortality (600 deaths, 20% mortality rate)",
                "Predictors: 150 variables extracted from EHR, 25 selected by importance ranking",
                "Validation: 5-fold cross-validation on same dataset",
                "Calibration: 'Good' (no plot shown)",
                "No external validation"
              ]
            },
            {
              heading: "Your Task:",
              text: "Valuta sistematicamente questo studio utilizzando i principi di questo corso."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'capstone-evaluation',
          title: "Capstone: Full Evaluation",
          situation: "Lavora attraverso ciascun ambito di valutazione per questo modello di mortalit√† COVID.",
          nodes: {
            start: {
              question: "FASE 1 - DIMENSIONE DEL CAMPIONE: Hanno 600 eventi e 25 predittori. Cos'√® l'EPV ed √® adeguato?",
              branches: [
                { text: "EPV = 600/25 = 24 ‚Äî adequate", nextNode: "epv_surface" },
                { text: "EPV = 600/150 = 4 ‚Äî they tested 150 variables", nextNode: "epv_correct" }
              ]
            },
            epv_surface: {
              type: 'outcome',
              outcome: 'partial',
              title: "Look deeper!",
              text: "They TESTED 150 variables before selecting 25. The effective degrees of freedom used is closer to 150. EPV = 600/150 = 4, which is critically low. Data-driven selection doesn't reduce overfitting ‚Äî it increases it.",
              lesson: "L'EPV dovrebbe contare TUTTE le variabili testate, non solo quelle conservate. La selezione non ti salva."
            },
            epv_correct: {
              situation: "Correct! Effective EPV is ~4, critically low. Now assess VALIDATION:",
              question: "Hanno utilizzato la convalida incrociata 5 volte sullo stesso set di dati. √à adeguato?",
              branches: [
                { text: "Yes ‚Äî cross-validation is rigorous internal validation", nextNode: "cv_inadequate" },
                { text: "No ‚Äî no external validation means unknown generalizability", nextNode: "cv_correct" }
              ]
            },
            cv_inadequate: {
              type: 'outcome',
              outcome: 'danger',
              title: "Cross-validation is internal only!",
              text: "Test CV 5 volte che si adattano eccessivamente ma non sono generalizzabili. I dati provengono ancora da un ospedale di New York durante il picco della pandemia. Un modello addestrato nell'aprile 2020 a New York potrebbe non funzionare nel luglio 2020 in Texas. √à richiesta la convalida esterna.",
              lesson: "Internal validation (CV, bootstrap) estimates optimism. External validation tests generalizability. Both are needed."
            },
            cv_correct: {
              situation: "Good! Now assess CALIBRATION:",
              question: "The paper says calibration is 'good' but shows no calibration plot. Your response:",
              branches: [
                { text: "Accept it ‚Äî they're experts who evaluated calibration", nextNode: "accept_wrong" },
                { text: "Reject ‚Äî without a calibration plot, claim is unverifiable", nextNode: "reject_correct" }
              ]
            },
            accept_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Trust but verify!",
              text: "'Good calibration' without a plot is meaningless. What threshold? What method? The COVID-19 model reviews found most papers didn't properly assess calibration. No plot = no evidence.",
              lesson: "TRIPOD richiede grafici di calibrazione. Le affermazioni senza prove non sono prove."
            },
            reject_correct: {
              situation: "Correct ‚Äî demand the calibration plot. Now OVERALL ASSESSMENT:",
              question: "Given everything, what is your PROBAST risk of bias judgment?",
              branches: [
                { text: "Moderate ‚Äî some concerns but promising", nextNode: "moderate_wrong" },
                { text: "High ‚Äî multiple critical flaws", nextNode: "high_correct" }
              ]
            },
            moderate_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Too generous!",
              text: "This study has: (1) High risk participants (single site, peak pandemic); (2) High risk analysis (EPV ~4, data-driven selection, no external validation, no calibration plot). Multiple domains at high risk = overall HIGH RISK.",
              lesson: "PROBAST √® intenzionalmente severo. Questo modello non dovrebbe informare la pratica clinica."
            },
            high_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct critical appraisal!",
              text: "You identified: critically low EPV, data-driven selection, internal-only validation, unverified calibration claim, single-site limitations. This is a HIGH risk of bias study. The C = 0.91 is likely massively optimistic. External performance is probably C = 0.65-0.75 at best.",
              lesson: "Questo studio rappresenta il 99% dei modelli COVID inutilizzabili. Una buona valutazione critica avrebbe impedito l'implementazione di tali modelli."
            }
          }
        }
      },
      {
        type: 'content',
        content: {
          title: "üéì Corso completato: cosa hai imparato",
          sections: [
            {
              heading: "You Can Now:",
              items: [
                "‚úì Distinguish prognostic factors from therapeutic targets",
                "‚úì Evaluate EPV and recognize overfitting risk",
                "‚úì Interpret C-statistics and calibration plots",
                "‚úì Distinguish internal from external validation",
                "‚úì Assess model bias using PROBAST",
                "‚úì Evaluate clinical prediction rules and their pathways",
                "‚úì Apply TRIPOD reporting standards",
                "‚úì Interpret decision curves and net benefit",
                "‚úì Compare ML to logistic regression appropriately",
                "‚úì Identify implementation barriers",
                "‚úì Critically appraise prognostic model studies"
              ]
            },
            {
              heading: "The Seven Principles:",
              items: [
                "1. La previsione non √® causalit√†",
                "2. A model is only as good as its validation",
                "3. La discriminazione non √® sufficiente",
                "4. Pi√π predittori non sono migliori",
                "5. La popolazione definisce la previsione",
                "6. Clinical utility trumps statistics",
                "7. Transparency enables trust"
              ]
            }
          ]
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A colleague presents a new readmission model with C = 0.82, excellent calibration, and positive net benefit across thresholds 10-30%. No external validation yet. The model should:",
          options: [
            { id: 'a', text: "Be deployed immediately ‚Äî performance is excellent", correct: false },
            { id: 'b', text: "Essere pubblicata come studio di sviluppo, con convalida esterna richiesta prima della distribuzione", correct: true },
            { id: 'c', text: "Be rejected ‚Äî no external validation means it's invalid", correct: false },
            { id: 'd', text: "Be used only for research purposes", correct: false }
          ],
          explanation: "Development + internal validation = publishable, but NOT deployable. External validation is required before clinical use. This is the appropriate staging: develop ‚Üí validate internally ‚Üí publish ‚Üí validate externally ‚Üí deploy. Skipping external validation leads to Epic Sepsis failures."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéì FINAL MASTERY: You've completed the Prognostic Reviews course. You can now evaluate prediction models rigorously, distinguishing genuine clinical value from statistical theater. Use these skills to protect patients from poorly validated algorithms and to champion models that truly improve care. Remember: every model is wrong, but some are useful. Your job is to tell the difference."
        }
      }
    ]
  }
];

// Render Functions
function renderModuleNav() {
  const nav = document.getElementById('module-nav');
  nav.innerHTML = modules.map((m, i) => `
    <button class="module-item ${i === currentModule ? 'active' : ''} ${gameState.modulesCompleted.includes(i) ? 'completed' : ''}"
            onclick="goToModule(${i})"
            aria-current="${i === currentModule ? 'true' : 'false'}">
      <div class="module-number">${gameState.modulesCompleted.includes(i) ? '‚úì' : i}</div>
      <div class="module-info">
        <div class="module-title">${m.title}</div>
        <div class="module-subtitle">${m.subtitle}${m.estimatedTime ? ` ¬∑ <span class="time-estimate">${m.estimatedTime}</span>` : ''}</div>
      </div>
    </button>
  `).join('');
}

function renderSlide() {
  const container = document.getElementById('slide-container');
  const module = modules[currentModule];
  const slide = module.slides[currentSlide];

  let html = '';

  switch(slide.type) {
    case 'title':
      html = `
        <div class="slide-title">
          <h1>${slide.content.title}</h1>
          <div class="subtitle">${slide.content.subtitle}</div>
          <p class="description">${slide.content.text}</p>
        </div>
      `;
      break;

    case 'principle-display':
      html = `
        <div class="principle-box">
          <div class="number">${module.principle !== null ? module.principle + 1 : ''}</div>
          <div class="text">"${slide.content.principle}"</div>
        </div>
      `;
      break;

    case 'principle':
      html = `
        <div class="principle-box" style="background: linear-gradient(135deg, rgba(107,70,193,0.15), rgba(30,39,97,0.1)); padding: 2rem;">
          <div class="text" style="font-size: 1.2rem; line-height: 1.6; white-space: pre-line;">${slide.content.text}</div>
        </div>
      `;
      break;

    case 'story-deep':
      html = renderStoryDeep(slide.content);
      break;

    case 'content':
      html = renderContent(slide.content);
      break;

    case 'method':
      html = renderMethod(slide.content);
      break;

    case 'decision-tree':
      html = renderDecisionTree(slide.content);
      break;

    case 'quiz':
      html = renderQuiz(slide.content);
      break;
  }

  container.innerHTML = html;
  updateNavButtons();
  updateProgress();

  // Announce slide change for screen readers
  const announcer = document.getElementById('slide-announce');
  if (announcer) {
    const module = modules[currentModule];
    announcer.textContent = `Slide ${currentSlide + 1} of ${module.slides.length}, Module: ${module.title}`;
  }
}

function renderStoryDeep(content) {
  let html = `<div class="story-deep">`;
  html += `<div class="story-label">${content.label}</div>`;
  html += `<div class="story-source">${content.source}</div>`;

  if (content.timeline) {
    html += `<div class="timeline">`;
    content.timeline.forEach(event => {
      html += `
        <div class="timeline-event ${event.type || ''}">
          <div class="timeline-year">${event.year}</div>
          <div class="timeline-text">${event.text}</div>
        </div>
      `;
    });
    html += `</div>`;
  }

  if (content.realData) {
    html += `<div class="real-data-box">`;
    html += `<h4>üìä Real Data</h4>`;
    html += `<div class="data-grid">`;
    Object.entries(content.realData).forEach(([key, value]) => {
      html += `
        <div class="data-item">
          <div class="data-label">${key}</div>
          <div class="data-value">${value}</div>
        </div>
      `;
    });
    html += `</div></div>`;
  }

  if (content.hook) {
    html += `<div class="hook-text">${content.hook}</div>`;
  }

  html += `</div>`;
  return html;
}

function renderContent(content) {
  let html = `<div class="content-box">`;
  html += `<h2>${content.title}</h2>`;

  content.sections.forEach(section => {
    html += `<div class="content-section">`;
    html += `<h3>${section.heading}</h3>`;
    if (section.items) {
      html += `<ul>`;
      section.items.forEach(item => {
        html += `<li>${item}</li>`;
      });
      html += `</ul>`;
    }
    if (section.text) {
      html += `<p>${section.text}</p>`;
    }
    html += `</div>`;
  });

  html += `</div>`;
  return html;
}

function renderMethod(content) {
  let html = `<div class="method-box">`;
  html += `<div class="method-label">${content.label}</div>`;
  html += `<h2>${content.title}</h2>`;

  content.sections.forEach(section => {
    html += `<div class="method-section">`;
    html += `<h3>${section.heading}</h3>`;
    html += `<p>${section.text}</p>`;
    html += `</div>`;
  });

  html += `</div>`;
  return html;
}

function renderDecisionTree(content) {
  const treeId = content.id;
  if (!gameState.decisionTrees[treeId]) {
    gameState.decisionTrees[treeId] = { currentNode: 'start', history: [] };
  }

  const currentNodeId = gameState.decisionTrees[treeId].currentNode;
  const currentNode = content.nodes[currentNodeId];

  let html = `<div class="decision-tree">`;
  html += `<h2>üå≥ ${content.title}</h2>`;

  if (currentNodeId === 'start') {
    html += `<div class="decision-situation">${content.situation}</div>`;
  }

  if (currentNode.type === 'outcome') {
    html += `
      <div class="decision-outcome ${currentNode.outcome}">
        <div class="outcome-title">${currentNode.title}</div>
        <div class="outcome-text">${currentNode.text}</div>
        <div class="outcome-lesson">${currentNode.lesson}</div>
      </div>
    `;
    html += `<div class="tree-controls">
      <button class="tree-btn" onclick="resetDecisionTree('${treeId}')">Try Again</button>
    </div>`;
  } else {
    if (currentNode.situation) {
      html += `<div class="decision-situation">${currentNode.situation}</div>`;
    }
    html += `<div class="decision-question">${currentNode.question}</div>`;
    html += `<div class="decision-branches">`;
    currentNode.branches.forEach((branch, i) => {
      html += `
        <button class="decision-branch" onclick="makeDecision('${treeId}', '${branch.nextNode}', '${branch.text.replace(/\\/g, '\\\\').replace(/'/g, "\\'")}')">
          ${branch.text}
        </button>
      `;
    });
    html += `</div>`;
  }

  html += `</div>`;
  return html;
}

function makeDecision(treeId, nextNode, choiceText) {
  if (!gameState.decisionTrees[treeId]) {
    gameState.decisionTrees[treeId] = { currentNode: 'start', history: [] };
  }
  gameState.decisionTrees[treeId].history.push(choiceText);
  gameState.decisionTrees[treeId].currentNode = nextNode;
  addPoints(10);
  saveProgress();
  renderSlide();
}

function resetDecisionTree(treeId) {
  gameState.decisionTrees[treeId] = { currentNode: 'start', history: [] };
  saveProgress();
  renderSlide();
}

function renderQuiz(content) {
  const quizId = `quiz_${currentModule}_${currentSlide}`;

  return `
    <div class="quiz-container">
      <div class="quiz-question">${content.question}</div>
      <div class="quiz-options" role="radiogroup" aria-label="Quiz options">
        ${content.options.map((opt, i) => `
          <button class="quiz-option" role="radio" aria-checked="false"
                  data-correct="${opt.correct}"
                  onclick="selectQuizOption(this, '${quizId}', ${opt.correct})">
            ${opt.text}
          </button>
        `).join('')}
      </div>
      <div class="quiz-feedback" id="feedback-${quizId}" role="alert" aria-live="polite">
        <p>${content.explanation}</p>
      </div>
    </div>
  `;
}

const _answeredQuizzes = new Set();

function selectQuizOption(element, quizId, isCorrect) {
  // Prevent re-answering after first answer
  if (_answeredQuizzes.has(quizId)) return;

  const container = element.closest('.quiz-container');
  const options = container.querySelectorAll('.quiz-option');
  const feedback = document.getElementById(`feedback-${quizId}`);

  options.forEach(opt => {
    opt.classList.remove('selected', 'correct', 'incorrect');
  });

  element.classList.add('selected');
  options.forEach(opt => opt.setAttribute('aria-checked', 'false'));
  element.setAttribute('aria-checked', 'true');

  if (isCorrect) {
    element.classList.add('correct');
    feedback.classList.add('show', 'correct');
    feedback.classList.remove('incorrect');
    addPoints(30);
  } else {
    element.classList.add('incorrect');
    feedback.classList.add('show', 'incorrect');
    feedback.classList.remove('correct');
    options.forEach(opt => {
      if (opt.dataset.correct === 'true') {
        opt.classList.add('correct');
      }
    });
  }

  // Lock quiz after answering
  _answeredQuizzes.add(quizId);
  options.forEach(opt => {
    opt.style.pointerEvents = 'none';
    opt.setAttribute('aria-disabled', 'true');
  });

  saveProgress();
}

// Navigation
function nextSlide() {
  const module = modules[currentModule];
  if (currentSlide < module.slides.length - 1) {
    currentSlide++;
  } else if (currentModule < modules.length - 1) {
    if (!gameState.modulesCompleted.includes(currentModule)) {
      gameState.modulesCompleted.push(currentModule);
      addPoints(100);
      checkBadges();
    }
    currentModule++;
    currentSlide = 0;
  }
  saveProgress();
  renderSlide();
  renderModuleNav();
  window.scrollTo(0, 0);
}

function prevSlide() {
  if (currentSlide > 0) {
    currentSlide--;
  } else if (currentModule > 0) {
    currentModule--;
    currentSlide = modules[currentModule].slides.length - 1;
  }
  saveProgress();
  renderSlide();
  renderModuleNav();
  window.scrollTo(0, 0);
}

function goToModule(moduleIndex) {
  currentModule = moduleIndex;
  currentSlide = 0;
  saveProgress();
  renderSlide();
  renderModuleNav();
  closeSidebar();
  window.scrollTo(0, 0);
}

function updateNavButtons() {
  const prevBtn = document.getElementById('prev-btn');
  const nextBtn = document.getElementById('next-btn');

  prevBtn.disabled = currentModule === 0 && currentSlide === 0;

  const isLastSlide = currentModule === modules.length - 1 &&
                      currentSlide === modules[currentModule].slides.length - 1;
  nextBtn.textContent = isLastSlide ? 'Complete Course' : 'Next ‚Üí';
}

function updateProgress() {
  let totalSlides = 0;
  let completedSlides = 0;

  modules.forEach((m, i) => {
    totalSlides += m.slides.length;
    if (i < currentModule) {
      completedSlides += m.slides.length;
    } else if (i === currentModule) {
      completedSlides += currentSlide;
    }
  });

  const percent = Math.round((completedSlides / totalSlides) * 100);
  document.getElementById('progress-fill').style.width = `${percent}%`;
  document.getElementById('progress-text').textContent = `${percent}% Complete`;
}

// Points and Badges
function addPoints(points) {
  gameState.points += points;
  document.getElementById('points-display').textContent = gameState.points;
}

function checkBadges() {
  const newBadges = [];

  // Story Collector: Read most case studies
  if (gameState.modulesCompleted.length >= 10 && !gameState.earnedBadges.includes('story-collector')) {
    newBadges.push('story-collector');
  }

  // Tree Navigator: Complete 15+ decision trees
  const treesCompleted = Object.keys(gameState.decisionTrees).filter(k =>
    gameState.decisionTrees[k].history && gameState.decisionTrees[k].history.length > 0
  ).length;
  if (treesCompleted >= 15 && !gameState.earnedBadges.includes('tree-navigator')) {
    newBadges.push('tree-navigator');
  }

  // Prognosis Master: Complete entire course
  if (gameState.modulesCompleted.length === 12 && !gameState.earnedBadges.includes('prognosis-master')) {
    newBadges.push('prognosis-master');
  }

  // Model Builder: Complete Module 2 (The Models)
  if (gameState.modulesCompleted.includes(2) && !gameState.earnedBadges.includes('model-builder')) {
    newBadges.push('model-builder');
  }

  // Validation Expert: Complete Module 4 (The Validation)
  if (gameState.modulesCompleted.includes(4) && !gameState.earnedBadges.includes('validation-expert')) {
    newBadges.push('validation-expert');
  }

  // Calibration Master: Complete Module 3 (The Performance)
  if (gameState.modulesCompleted.includes(3) && !gameState.earnedBadges.includes('calibration-master')) {
    newBadges.push('calibration-master');
  }

  // TRIPOD Scholar: Complete Module 6 (The Reporting)
  if (gameState.modulesCompleted.includes(6) && !gameState.earnedBadges.includes('tripod-scholar')) {
    newBadges.push('tripod-scholar');
  }

  // Decision Analyst: Complete Module 7 (The Utility)
  if (gameState.modulesCompleted.includes(7) && !gameState.earnedBadges.includes('decision-analyst')) {
    newBadges.push('decision-analyst');
  }

  // Penalization Pro: Complete penalization decision tree
  if (gameState.decisionTrees['penalization-choice'] &&
      gameState.decisionTrees['penalization-choice'].history &&
      gameState.decisionTrees['penalization-choice'].history.length > 0 &&
      !gameState.earnedBadges.includes('penalization-pro')) {
    newBadges.push('penalization-pro');
  }

  // Patient Communicator: Complete calibration-plot-reading tree (communication content)
  if (gameState.decisionTrees['calibration-plot-reading'] &&
      gameState.decisionTrees['calibration-plot-reading'].history &&
      gameState.decisionTrees['calibration-plot-reading'].history.length > 0 &&
      !gameState.earnedBadges.includes('communicator')) {
    newBadges.push('communicator');
  }

  // AI Skeptic: Complete Module 9 (ML vs Regression)
  if (gameState.modulesCompleted.includes(9) && !gameState.earnedBadges.includes('skeptic')) {
    newBadges.push('skeptic');
  }

  // Implementation Expert: Complete Module 10 (The Implementation)
  if (gameState.modulesCompleted.includes(10) && !gameState.earnedBadges.includes('implementer')) {
    newBadges.push('implementer');
  }

  newBadges.forEach(badge => {
    gameState.earnedBadges.push(badge);
    showBadgeNotification(badge);
  });

  if (newBadges.length > 0) saveProgress();
}

function showBadgeNotification(badgeId) {
  const badge = BADGES[badgeId];
  if (!badge) return;

  const notification = document.createElement('div');
  notification.className = 'badge-notification';
  notification.innerHTML = `
    <div class="badge-icon" style="background: ${badge.color}">${badge.icon}</div>
    <div class="badge-info">
      <div class="badge-earned">Badge Earned!</div>
      <div class="badge-name">${badge.name}</div>
    </div>
  `;
  document.body.appendChild(notification);

  setTimeout(() => notification.classList.add('show'), 100);
  setTimeout(() => {
    notification.classList.remove('show');
    setTimeout(() => notification.remove(), 500);
  }, 3000);
}

// Persistence
function saveProgress() {
  try {
    localStorage.setItem(STORAGE_KEY, JSON.stringify({
      currentModule,
      currentSlide,
      gameState
    }));
  } catch (e) {
    console.log('Could not save progress:', e);
  }
}

function loadProgress() {
  try {
    const saved = localStorage.getItem(STORAGE_KEY);
    if (saved) {
      const data = JSON.parse(saved);
      if (data.gameState) {
        gameState = { ...gameState, ...data.gameState };
      }
      if (typeof data.currentModule === 'number' && data.currentModule >= 0 && data.currentModule < modules.length) {
        currentModule = data.currentModule;
      }
      if (typeof data.currentSlide === 'number' && data.currentSlide >= 0) {
        currentSlide = Math.min(data.currentSlide, modules[currentModule].slides.length - 1);
      }
    }
  } catch (e) {
    console.log('Could not load progress:', e);
  }
}

// Mobile Menu
function toggleSidebar() {
  const sidebar = document.querySelector('.sidebar');
  const overlay = document.querySelector('.sidebar-overlay');
  sidebar.classList.toggle('open');
  overlay.classList.toggle('show');
}

function closeSidebar() {
  const sidebar = document.querySelector('.sidebar');
  const overlay = document.querySelector('.sidebar-overlay');
  sidebar.classList.remove('open');
  overlay.classList.remove('show');
}

// Modal utilities: close by ID, Escape key handler
function closeModalOverlay(id) {
  const el = document.getElementById(id);
  if (el) el.remove();
}

function _attachModalEscapeHandler(overlayId) {
  function handler(e) {
    if (e.key === 'Escape') {
      closeModalOverlay(overlayId);
      document.removeEventListener('keydown', handler);
    }
  }
  document.addEventListener('keydown', handler);
}

// Badges Modal
function openBadges() {
  const earnedCount = gameState.earnedBadges.length;
  const totalCount = Object.keys(BADGES).length;

  const html = `
    <div id="badges-modal-overlay" role="dialog" aria-modal="true" aria-label="Badges" style="position: fixed; inset: 0; background: rgba(0,0,0,0.5); z-index: 2000; display: flex; align-items: center; justify-content: center; padding: 1rem;">
      <div style="background: white; border-radius: 12px; max-width: 700px; max-height: 80vh; overflow-y: auto; padding: 2rem;">
        <div style="display: flex; justify-content: space-between; align-items: center; margin-bottom: 1rem;">
          <h2 style="font-family: 'Cormorant Garamond', serif; color: var(--navy);">üèÜ Badges (${earnedCount}/${totalCount})</h2>
          <button id="badges-modal-close" onclick="closeModalOverlay('badges-modal-overlay')" style="background: none; border: none; font-size: 1.5rem; cursor: pointer;" aria-label="Close badges">&times;</button>
        </div>
        <div class="badge-grid">
          ${Object.entries(BADGES).map(([id, badge]) => {
            const earned = gameState.earnedBadges.includes(id);
            return `
              <div class="badge-card ${earned ? 'earned' : 'locked'}">
                <div class="badge-icon" style="background: ${badge.color}">${badge.icon}</div>
                <div style="font-weight: 600; color: var(--navy); margin-top: 0.5rem;">${badge.name}</div>
                <div style="font-size: 0.75rem; color: var(--light-text);">${earned ? '‚úì Earned!' : badge.requirement}</div>
              </div>
            `;
          }).join('')}
        </div>
      </div>
    </div>
  `;

  document.body.insertAdjacentHTML('beforeend', html);
  const closeBtn = document.getElementById('badges-modal-close');
  if (closeBtn) closeBtn.focus();
  _attachModalEscapeHandler('badges-modal-overlay');
}

// Glossary
function openGlossary() {
  const terms = [
    { term: "Prognostic Factor", def: "A variable associated with future clinical outcomes in patients with a condition." },
    { term: "C-Statistic (AUC)", def: "Measure of discrimination; probability that a random case is ranked higher than a random non-case." },
    { term: "Calibration", def: "Agreement between predicted probabilities and observed event rates." },
    { term: "Calibration Plot", def: "Graph showing predicted vs observed probabilities across risk groups." },
    { term: "Calibration-in-the-Large", def: "Overall agreement between total predicted and observed events; expressed as P/O ratio." },
    { term: "Overfitting", def: "When a model learns noise in training data rather than true signal; causes poor generalization." },
    { term: "EPV", def: "Events Per Variable; ratio of outcome events to predictors. Should be ‚â•10, preferably ‚â•20." },
    { term: "Internal Validation", def: "Testing model on same data source (bootstrap, cross-validation)." },
    { term: "External Validation", def: "Testing model on completely independent data (different time, place, or population)." },
    { term: "Temporal Validation", def: "External validation using data from a different time period at the same site." },
    { term: "Geographic Validation", def: "External validation using data from a different location or institution." },
    { term: "TRIPOD", def: "Transparent Reporting of prediction models; 22-item reporting guideline." },
    { term: "PROBAST", def: "Prediction model Risk Of Bias Assessment Tool; evaluates bias in prediction studies." },
    { term: "Decision Curve", def: "Graph showing net benefit across treatment thresholds; assesses clinical utility." },
    { term: "Net Benefit", def: "True positives minus weighted false positives; measures clinical value of predictions." },
    { term: "Shrinkage", def: "Reducing model coefficients to correct for optimism from overfitting." },
    { term: "Calibration Slope", def: "Regression of outcomes on predictions; slope=1 is ideal, <1 indicates overfitting." },
    { term: "Clinical Prediction Rule", def: "Scoring system using clinical data to estimate probability or guide decisions." },
    { term: "Treatment Threshold", def: "Probability above which treatment is indicated; reflects benefit-harm tradeoff." },
    { term: "LASSO", def: "Least Absolute Shrinkage and Selection Operator; penalization method that shrinks coefficients and sets some to zero." },
    { term: "Ridge Regression", def: "Penalization method that shrinks all coefficients toward zero but never exactly to zero." },
    { term: "Elastic Net", def: "Penalization combining LASSO (L1) and Ridge (L2); balances selection and grouped shrinkage." },
    { term: "Recalibration", def: "Updating model intercept and/or slope to improve calibration in a new population." },
    { term: "Competing Risks", def: "When patients can experience multiple mutually exclusive events (e.g., death prevents later fracture)." },
    { term: "Subdistribution Hazard", def: "Hazard function that accounts for competing risks (Fine-Gray method)." },
    { term: "Cumulative Incidence", def: "Probability of event accounting for competing risks; preferred over 1-KM when competing events occur." },
    { term: "Prediction Interval", def: "Range of predicted probabilities expected in future similar patients; wider than confidence interval." },
    { term: "Brier Score", def: "Overall measure combining discrimination and calibration; average squared difference between predicted and observed." }
  ];

  const html = `
    <div id="glossary-modal-overlay" role="dialog" aria-modal="true" aria-label="Glossary" style="position: fixed; inset: 0; background: rgba(0,0,0,0.5); z-index: 2000; display: flex; align-items: center; justify-content: center; padding: 1rem;">
      <div style="background: white; border-radius: 12px; max-width: 600px; max-height: 80vh; overflow-y: auto; padding: 2rem;">
        <div style="display: flex; justify-content: space-between; align-items: center; margin-bottom: 1rem;">
          <h2 style="font-family: 'Cormorant Garamond', serif; color: var(--navy);">Glossary</h2>
          <button id="glossary-modal-close" onclick="closeModalOverlay('glossary-modal-overlay')" style="background: none; border: none; font-size: 1.5rem; cursor: pointer;" aria-label="Close glossary">&times;</button>
        </div>
        ${terms.map(t => `
          <div style="margin-bottom: 1rem; padding-bottom: 1rem; border-bottom: 1px solid rgba(0,0,0,0.1);">
            <strong style="color: var(--purple);">${t.term}</strong>
            <p style="margin-top: 0.25rem; color: var(--navy);">${t.def}</p>
          </div>
        `).join('')}
      </div>
    </div>
  `;

  document.body.insertAdjacentHTML('beforeend', html);
  const closeBtn = document.getElementById('glossary-modal-close');
  if (closeBtn) closeBtn.focus();
  _attachModalEscapeHandler('glossary-modal-overlay');
}

// Initialize
document.addEventListener('DOMContentLoaded', () => {
  loadProgress();
  renderModuleNav();
  renderSlide();
  document.getElementById('points-display').textContent = gameState.points;

  document.querySelector('.hamburger').addEventListener('click', toggleSidebar);
  document.querySelector('.sidebar-overlay').addEventListener('click', closeSidebar);

  document.addEventListener('keydown', (e) => {
    if (e.key === 'ArrowRight' && !e.target.matches('input, textarea, button, select, [role="button"]')) {
      nextSlide();
    } else if (e.key === 'ArrowLeft' && !e.target.matches('input, textarea, button, select, [role="button"]')) {
      prevSlide();
    }
  });
});
</script>
</body>
</html>
